syndrome	score	normalized_score
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	2.333333	100.0
SYNDACTYLY, TYPE IV; SDTY4	2.0243902	86.75959239422748
COLE-CARPENTER SYNDROME 1; CLCRP1	1.2490338600000002	53.53003021857575
TOWNES-BROCKS SYNDROME 1; TBS1	1.1719111219999998	50.22476954639564
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	1.16060766	49.74033539147648
POLYDACTYLY, PREAXIAL IV; PPD4	1.142857	48.97959271137039
Congenital disorder of glycosylation, type IIh	1.1118393619999998	47.650265178609295
CRANIOSYNOSTOSIS 4; CRS4	1.0714286	45.91837513119644
OTOSCLEROSIS 7	1.06490139	45.63863751980536
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	1.06235161	45.52936121848017
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	1.0592106	45.394746484963775
DEAFNESS, AUTOSOMAL DOMINANT 1	1.05810013	45.34715490673641
DEAFNESS, AUTOSOMAL DOMINANT 6	1.03125	44.19643488520498
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	1.00798692	43.1994455999208
COFFIN-SIRIS SYNDROME 1; CSS1	1.004912692	43.067692952527565
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.00406881	43.03152657593236
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.003637182	43.0130282304326
PEROXISOME BIOGENESIS DISORDER 11B	1.0027933	42.976861853837406
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	1.00127551	42.91181370168767
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	1.000843882	42.89331535618791
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.0	42.85714897959271
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	1.0	42.85714897959271
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	1.0	42.85714897959271
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	1.0	42.85714897959271
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	1.0	42.85714897959271
HYDROLETHALUS SYNDROME 1	1.0	42.85714897959271
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	1.0	42.85714897959271
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	1.0	42.85714897959271
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	1.0	42.85714897959271
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	42.85714897959271
CRANIOSYNOSTOSIS 2	1.0	42.85714897959271
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.833333	35.71427653061093
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.7909090999999999	33.89610912801558
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.743276442	31.854709207815603
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.734801862	31.49151287021612
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.7098521499999999	30.422239346034186
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.7	30.000004285714894
OCULODENTODIGITAL DYSPLASIA; ODDD	0.68399871	29.31423461631923
SCLEROSTEOSIS 1; SOST1	0.67733432	29.028617861231126
FILIPPI SYNDROME; FLPIS	0.6647051300000001	28.487366783909547
ZIMMERMANN-LABAND SYNDROME 1	0.5937024	25.444392206341742
POTOCKI-LUPSKI SYNDROME	0.543374192	23.287468698209814
BRANCHIOOTORENAL SYNDROME 1	0.5416667	23.214290459184348
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.53125	22.767860395408626
SYNDACTYLY, TYPE V	0.53125	22.767860395408626
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.5243902	22.47386892483842
SCALP-EAR-NIPPLE SYNDROME; SENS	0.5243902	22.47386892483842
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.522205422	22.380235568605077
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.520530332	22.30844598692085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.517394922	22.17407125343875
DEAFNESS AND MYOPIA; DFNMYP	0.50934579	21.829108404158344
TRICHOHEPATOENTERIC SYNDROME 1	0.50787402	21.766032538004648
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.5051681720000001	21.65006760715252
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.50406881	21.602952086136014
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.5027933	21.54828736404105
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.50254453	21.537625791089397
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.50127551	21.483239211891316
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.500843882	21.464740866391548
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.5	21.428574489796354
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.5	21.428574489796354
IMMUNODEFICIENCY 36; IMD36	0.5	21.428574489796354
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.5	21.428574489796354
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.5	21.428574489796354
POTOCKI-SHAFFER SYNDROME	0.5	21.428574489796354
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.5	21.428574489796354
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	21.428574489796354
OSSICULAR MALFORMATIONS, FAMILIAL	0.5	21.428574489796354
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.5	21.428574489796354
DEAFNESS, UNILATERAL	0.5	21.428574489796354
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.5	21.428574489796354
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.5	21.428574489796354
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.5	21.428574489796354
OROFACIODIGITAL SYNDROME I; OFD1	0.47935546	20.543808363401194
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.45	19.28571704081672
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.4305556	18.452385493197927
DESBUQUOIS DYSPLASIA 2; DBQD2	0.401930792	17.225607832229688
SYNPOLYDACTYLY 1	0.40060924000000003	17.168969881281413
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.37526282200000005	16.082694668956382
Jawad syndrome	0.36751088200000004	15.750468621495518
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.364583	15.624987946426849
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.36363599999999996	15.584402226343173
KENNERKNECHT SYNDROME	0.3541663	15.178557882651125
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.3536702	15.157296451042349
AL KAISSI SYNDROME; ALKAS	0.345212582	14.794827056403864
TERMINAL OSSEOUS DYSPLASIA; TOD	0.34180758	14.648898378414055
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.340477522	14.591895884556552
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.339202012	14.537231162461595
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.33802783999999997	14.486909498129927
CANAVAN DISEASE	0.3361263	14.405414915059273
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.33460850999999997	14.340366762909534
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.334176882	14.321868417409775
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.3333333	14.28571489795927
#601369 DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	0.333333	14.285702040814577
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	0.333333	14.285702040814577
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.333333	14.285702040814577
SYNDACTYLY, TYPE III	0.333333	14.285702040814577
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.2916667	12.500003214286174
CHROMOSOME 2q35 DUPLICATION SYNDROME	0.28530279999999997	12.227264603894941
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.2602504	11.153590164798594
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.25502513	10.929649989949999
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.25469484	10.915494702213527
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.25382003999999997	10.878003268286179
COCKAYNE SYNDROME A; CSA	0.25382003999999997	10.878003268286179
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.250843882	10.750453621493374
HYDROCEPHALUS, NORMAL-PRESSURE	0.250843882	10.750453621493374
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.25	10.714287244898177
FECHTNER SYNDROME	0.25	10.714287244898177
ANEURYSM, INTRACRANIAL BERRY, 3	0.25	10.714287244898177
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.25	10.714287244898177
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.25	10.714287244898177
#612643 DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	0.25	10.714287244898177
DYSTONIA 6, TORSION	0.25	10.714287244898177
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	10.714287244898177
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.25	10.714287244898177
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.25	10.714287244898177
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.25	10.714287244898177
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	10.714287244898177
HYPERPARATHYROIDISM 2	0.25	10.714287244898177
POLYCYSTIC KIDNEYS	0.25	10.714287244898177
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.25	10.714287244898177
ANEURYSM, INTRACRANIAL BERRY, 2	0.25	10.714287244898177
CORNELIA DE LANGE SYNDROME 3	0.24714782200000002	10.592051027435861
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.24347816	10.43477977639711
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.22519799999999998	9.651344235906318
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.2215436	9.494727070675296
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.22070361	9.458727494103927
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.22048704	9.449445921349417
LOEYS-DIETZ SYNDROME 3; LDS3	0.22006912	9.431535061647866
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.21788246	9.33782104826015
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.21608564	9.260814465830638
MARFAN SYNDROME; MFS	0.21590910000000002	9.253248464749781
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.20934579	8.97196371028053
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.20723937	8.881688554526935
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.205869012	8.822958917565558
ROSSELLI-GULIENETTI SYNDROME	0.205253882	8.796596199513743
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.20440999999999998	8.760429822918544
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.20224504	8.667645809663686
SECKEL SYNDROME 10; SCKL10	0.20127551000000002	8.626094518013502
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.200843882	8.60759617251374
CURRY-JONES SYNDROME	0.200315402	8.584947026421004
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.2	8.571429795918542
AORTIC ANEURYSM, ABDOMINAL	0.2	8.571429795918542
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.2	8.571429795918542
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.2	8.571429795918542
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.2	8.571429795918542
#615706 AURICULOCONDYLAR SYNDROME 3; ARCND3	0.2	8.571429795918542
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.2	8.571429795918542
AUROCEPHALOSYNDACTYLY	0.19919930000000002	8.537114076730584
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.19797980200000004	8.484849869264268
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.19652775000000003	8.422619060374153
FEINGOLD SYNDROME 1; FGLDS1	0.19512601000000002	8.362544480363496
CHROMOSOME 1P36 DELETION SYNDROME	0.18794179200000002	8.054649379235626
CROUZON SYNDROME	0.18675269	8.003687857669693
FLOATING-HARBOR SYNDROME	0.18376473000000002	7.875632410804631
CDAGS SYNDROME	0.180795312	7.748371621195946
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.17685667200000002	7.579572739938964
BRACHYDACTYLY, TYPE B2	0.17665153	7.570780938682992
KAPUR-TORIELLO SYNDROME	0.17601279	7.543406363343766
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.175497802	7.5213354459050645
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.17501586	7.50068078581154
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.175	7.5000010714287235
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.166667	7.1428724489817785
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.166667	7.1428724489817785
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.166667	7.1428724489817785
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.166667	7.1428724489817785
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.166667	7.1428724489817785
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.166667	7.1428724489817785
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.166667	7.1428724489817785
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.166667	7.1428724489817785
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.166667	7.1428724489817785
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.16382934000000002	7.021258431608348
CHROMOSOME 18Q DELETION SYNDROME	0.16369397000000002	7.015456859350981
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.15073102	6.459901779985968
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.15060894	6.4546697792385395
BASAN SYNDROME	0.14285699999999998	6.1224437317776745
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.14285699999999998	6.1224437317776745
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.142524422	6.108190386884341
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.14180141999999998	6.077204582457797
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.139335972	5.971542510220358
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.13757956199999996	5.89626778518111
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.13694198000000002	5.868942838420406
KLEEBLATTSCHAEDEL SYNDROME	0.13673568	5.8601014085859156
PETTIGREW SYNDROME	0.133943972	5.740456762922394
3MC SYNDROME 1	0.13328014000000002	5.712006816000974
ACROCALLOSAL SYNDROME; ACLS	0.13225574	5.6681039525862795
FONTAINE PROGEROID SYNDROME; FPS	0.13155936000000001	5.6382590911798705
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.12833648000000003	5.500135642876521
COLE-CARPENTER SYNDROME 2; CLCRP2	0.12833648000000003	5.500135642876521
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.12754453	5.4661949237421315
DEAFNESS, X-LINKED 4	0.12754453	5.4661949237421315
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.12635488	5.415209916458559
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.12627551	5.411808344544049
#612644 DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	0.125	5.3571436224490885
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.125	5.3571436224490885
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.125	5.3571436224490885
#614042 MOYAMOYA DISEASE 5; MYMY5	0.125	5.3571436224490885
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.125	5.3571436224490885
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.125	5.3571436224490885
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.12203697	5.230156604308086
#256520 NEU-LAXOVA SYNDROME; NLS	0.12002754	5.144038163434024
OROFACIODIGITAL SYNDROME IV; OFD4	0.11845381	5.0765925823703695
THANATOPHORIC DYSPLASIA, TYPE I	0.11751044199999999	5.036162519451788
MEIER-GORLIN SYNDROME 7	0.115068102	4.93149079021297
SCARF SYNDROME	0.1149069	4.924582132083162
HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	0.1149069	4.924582132083162
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.11189032000000002	4.795300113614302
THANATOPHORIC DYSPLASIA, TYPE II	0.11111099999999999	4.761900680271525
MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL	0.11111099999999999	4.761900680271525
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.11087801000000001	4.751915393130771
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.10928233999999999	4.683529526218503
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.10847458	4.648911235558748
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.10847458	4.648911235558748
GRANGE SYNDROME; GRNG	0.10847458	4.648911235558748
HOLT-ORAM SYNDROME	0.10847458	4.648911235558748
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.1072201	4.595147799306829
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.1055556	4.523812074830296
SPLIT-HAND/FOOT MALFORMATION 6	0.10416660000000001	4.464283494897643
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.10416660000000001	4.464283494897643
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.10363718200000001	4.441594148799164
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.10084388200000001	4.3218812745544675
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.1	4.285714897959271
LISSENCEPHALY 5; LIS5	0.09925796	4.253913179130454
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.09730854200000001	4.170366681480955
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.09646466000000001	4.134200304885758
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.09646466000000001	4.134200304885758
#614483 PORENCEPHALY 2; POREN2	0.09644782200000002	4.13347867621124
MEESTER-LOEYS SYNDROME; MRLS	0.09590216000000001	4.110093158584737
TIETZ SYNDROME	0.0954545	4.0909077272725325
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.09475381000000001	4.0608781515540215
CRANIOECTODERMAL DYSPLASIA 4	0.09375	4.017857716836817
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.09320463200000001	3.994484799212114
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.09192912200000002	3.9398200771171545
ALSTROM SYNDROME; ALMS	0.09091738199999999	3.89645978520854
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.0909091	3.896104842300692
AORTIC VALVE DISEASE 3; AOVD3	0.0909091	3.896104842300692
Contractural arachnodactyly, congenital	0.0909091	3.896104842300692
MARFANOID HABITUS WITH SITUS INVERSUS	0.0909091	3.896104842300692
EHLERS-DANLOS SYNDROME, TYPE I	0.0909091	3.896104842300692
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0909091	3.896104842300692
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0909091	3.896104842300692
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.0909091	3.896104842300692
VELOCARDIOFACIAL SYNDROME	0.09040200999999999	3.8743724106246296
DEAFNESS, AUTOSOMAL DOMINANT 50	0.08935013	3.8292918327559757
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.087772	3.7616576802368114
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.08697048200000002	3.727306903900987
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.08680560000000001	3.720240531462933
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.08661862000000001	3.7122271017467288
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.08612660000000001	3.6911405273057896
GLYCOGEN STORAGE DISEASE II	0.08612660000000001	3.6911405273057896
ALKAPTONURIA	0.08585860000000001	3.679654811379259
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.08477144199999999	3.633062319008902
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.08460881	3.6260923751560536
ANEURYSM, INTRACRANIAL BERRY, 1	0.08333330000000001	3.571427653061094
SPLIT-HAND/FOOT MALFORMATION 2	0.08333330000000001	3.571427653061094
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.08333330000000001	3.571427653061094
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.08333330000000001	3.571427653061094
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.08333330000000001	3.571427653061094
POLYCYSTIC KIDNEY DISEASE 3	0.08333330000000001	3.571427653061094
KOOLEN-DE VRIES SYNDROME; KDVS	0.082962512	3.555536736505248
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.082065192	3.51708015958288
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.08125	3.482143354591908
DEAFNESS, AUTOSOMAL DOMINANT 20	0.08125	3.482143354591908
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.080940162	3.4688645812663683
TARP SYNDROME; TARPS	0.080654792	3.4566344366620623
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.0800439	3.430453347207621
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0788235	3.378150482592926
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0788235	3.378150482592926
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.07838642200000001	3.359418565631224
WEAVER SYNDROME	0.077270772	3.311604987372141
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.07692310000000001	3.2967047566721086
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.07692310000000001	3.2967047566721086
#601869 DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15;;DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;;DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95	0.07692310000000001	3.2967047566721086
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.07692310000000001	3.2967047566721086
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.07692310000000001	3.2967047566721086
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.07692310000000001	3.2967047566721086
COFFIN-SIRIS SYNDROME 7; CSS7	0.075897372	3.2527449789635683
SILVER-RUSSELL SYNDROME; SRS	0.075531902	3.2370819767259964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.07551187	3.236223462317637
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0744235	3.189579027082718
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.07309950000000001	3.132836161833738
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.073066142	3.131406533058076
CRANIOFRONTONASAL SYNDROME; CFNS	0.072907422	3.1246042463720354
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.07229411	3.098319442617063
CRANIOECTODERMAL DYSPLASIA 3	0.07097458	3.041768148824021
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.070559362	3.023973089139013
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.070559362	3.023973089139013
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.070559362	3.023973089139013
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.06971548	2.987806712543816
WHITE-SUTTON SYNDROME; WHSUS	0.069663292	2.9855700836528687
FOCAL DERMAL HYPOPLASIA; FDH	0.06933106999999998	2.97133199590457
CRANIOECTODERMAL DYSPLASIA 1	0.06921141	2.9662037094576728
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.06805556	2.9166672738096104
AICARDI SYNDROME; AIC	0.06794220999999999	2.911809415972773
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.067510582	2.89331107047301
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.06729808	2.884203840600548
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.06717854999999999	2.879081125583017
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0666667	2.8571446938778133
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0666667	2.8571446938778133
GLUTARIC ACIDEMIA I; GA1	0.0666667	2.8571446938778133
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.066572782	2.853119636159948
Temtamy preaxial brachydactyly syndrome	0.066029872	2.8298520614074376
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.06588841200000001	2.8237894891127846
#150250 LARSEN SYNDROME; LRS	0.06490139	2.781488540212649
TIMOTHY SYNDROME; TS	0.064874062	2.7803173400453343
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.06470513	2.7730773961539135
ELSAHY-WATERS SYNDROME; ESWS	0.06427350200000001	2.7545790506541503
Muenke syndrome	0.064245442	2.7533764790537827
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.06421123	2.7519102502728923
NOONAN SYNDROME 3; NS3	0.063343882	2.714738187819741
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.062267010000000005	2.668586524083789
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0616168	2.6407203772457684
TEMTAMY SYNDROME; TEMTYS	0.061094322	2.618328459761208
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.0609616	2.612640373234339
HALLERMANN-STREIFF SYNDROME; HSS	0.06009901	2.575672225096032
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.059448262	2.54778302111186
ACRORENAL-MANDIBULAR SYNDROME	0.0592948	2.541206077315154
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0592948	2.541206077315154
SWEENEY-COX SYNDROME; SWCOS	0.059192782000000006	2.536833876690554
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	2.522987503283929
WIDOW&#39;S PEAK SYNDROME	0.0588235	2.521007503001072
EPISODIC ATAXIA, TYPE 1; EA1	0.0588235	2.521007503001072
245800 LAURENCE-MOON SYNDROME	0.0588235	2.521007503001072
MUCOLIPIDOSIS III GAMMA	0.0588235	2.521007503001072
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0588235	2.521007503001072
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.0588235	2.521007503001072
DERMOCHONDROCORNEAL DYSTROPHY	0.0588235	2.521007503001072
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0588235	2.521007503001072
Fabry disease	0.0588235	2.521007503001072
OSTEOGENESIS IMPERFECTA, TYPE I	0.0583489	2.500667500095357
Split hand/foot malformation 1 (SHFM1)	0.058184730000000004	2.4936316419473776
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.05810013000000001	2.490005927143704
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.05810013000000001	2.490005927143704
DEAFNESS, MID-TONE NEURAL	0.05810013000000001	2.490005927143704
WITTEVEEN-KOLK SYNDROME	0.057744922	2.4747827249689607
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.456974636710662
RAINE SYNDROME	0.057215671999999995	2.452100578871511
FEINGOLD SYNDROME 2; FGLDS2	0.056831110000000004	2.435619347945621
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.056399482	2.417121002445857
PHACE ASSOCIATION	0.056399482	2.417121002445857
CORNELIA DE LANGE SYNDROME 1	0.056230770000000006	2.4098904871272127
#613453 DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	0.055555600000000004	2.380954625850661
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.055555600000000004	2.380954625850661
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.055555600000000004	2.380954625850661
PEROXISOME BIOGENESIS DISORDER 14B	0.055555600000000004	2.380954625850661
FRASER SYNDROME 2; FRASRS2	0.055555600000000004	2.380954625850661
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.055555600000000004	2.380954625850661
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.055555600000000004	2.380954625850661
PERRAULT SYNDROME 4	0.055555600000000004	2.380954625850661
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.055555600000000004	2.380954625850661
#604308 MASS SYNDROME;;MASS PHENOTYPE;;OVERLAP CONNECTIVE TISSUE DISEASE; OCTD	0.055555600000000004	2.380954625850661
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	2.380954625850661
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.055555600000000004	2.380954625850661
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.055555600000000004	2.380954625850661
MARFANOID HYPERMOBILITY SYNDROME	0.055555600000000004	2.380954625850661
FRASER SYNDROME 3; FRASRS3	0.055555600000000004	2.380954625850661
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.055555600000000004	2.380954625850661
AORTIC VALVE DISEASE 2; AOVD2	0.055555600000000004	2.380954625850661
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.055555600000000004	2.380954625850661
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.055555600000000004	2.380954625850661
#613780 AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7;;AORTIC DISSECTION, FAMILIAL, WITH OR WITHOUT AORTIC ANEURYSM	0.055555600000000004	2.380954625850661
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.055555600000000004	2.380954625850661
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.05480029	2.3485841926548847
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.05442277	2.332404761772109
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.054145620000000005	2.3205269029324147
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.053399282000000006	2.2885409840772835
YUNIS-VARON SYNDROME	0.053184329999999995	2.2793287541898217
CHROMOSOME 17q12 DELETION SYNDROME	0.053048780000000004	2.2735194676456385
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.05297544	2.2703763243394746
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.05260389	2.254452750636107
MECKEL SYNDROME, TYPE 1; MKS1	0.05232006	2.2422886060412295
FRONTOOCULAR SYNDROME	0.052196202000000004	2.236980405282915
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.051963169999999996	2.2269933181419024
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.051963169999999996	2.2269933181419024
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.051250000000000004	2.1964288852041265
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.051136299999999996	2.1915560273651464
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.051101610000000006	2.190069312867045
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.050472272	2.1630976804425255
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.05	2.1428574489796355
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.05	2.1428574489796355
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.05	2.1428574489796355
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.05	2.1428574489796355
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.05	2.1428574489796355
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.05	2.1428574489796355
#610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	0.05	2.1428574489796355
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.05	2.1428574489796355
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05	2.1428574489796355
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.05	2.1428574489796355
VAN MALDERGEM SYNDROME 1; VMLDS1	0.049851730000000004	2.1365030195004313
VAN MALDERGEM SYNDROME 2; VMLDS2	0.049851730000000004	2.1365030195004313
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.04962324	2.1267105895300844
OTOFACIOCERVICAL SYNDROME 2	0.048378109999999995	2.0733478676211234
OHDO SYNDROME	0.04808914	2.060963437280491
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0478469	2.050581721511674
CHROMOSOME 10Q26 DELETION SYNDROME	0.047452512	2.0336793762399106
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.04742686	2.0325800046542866
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.047192939999999996	2.0225548603649797
#614976 CARPENTER SYNDROME 2; CRPT2	0.046833512	2.007150801021543
INFANTILE SIALIC ACID STORAGE DISEASE	0.046807641999999997	2.0060420865774407
PERRAULT SYNDROME 3	0.04673001	2.002715000387857
BARATELA-SCOTT SYNDROME	0.045763962	1.9613129373304192
USHER SYNDROME, TYPE IE; USH1E	0.0454545	1.9480502782928968
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0454545	1.9480502782928968
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.0454545	1.9480502782928968
DEAFNESS, X-LINKED 3	0.0454545	1.9480502782928968
USHER SYNDROME, TYPE IC	0.0454545	1.9480502782928968
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.0454545	1.9480502782928968
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.0454545	1.9480502782928968
PENDRED SYNDROME	0.0454545	1.9480502782928968
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.0454545	1.9480502782928968
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.0454545	1.9480502782928968
USHER SYNDROME, TYPE IIA	0.0454545	1.9480502782928968
USHER SYNDROME, TYPE IIC	0.0454545	1.9480502782928968
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.0454545	1.9480502782928968
USHER SYNDROME, TYPE IF	0.0454545	1.9480502782928968
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.0454545	1.9480502782928968
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.0454545	1.9480502782928968
DEAFNESS-OLIGODONTIA SYNDROME	0.0454545	1.9480502782928968
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0454545	1.9480502782928968
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0454545	1.9480502782928968
PHELAN-MCDERMID SYNDROME; PHMDS	0.044798451999999996	1.9199339314191328
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.044383019999999995	1.9021297003042428
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.044232971999999995	1.8956990708141528
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.04421123	1.8947672706810383
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.04421123	1.8947672706810383
HUNTER-MACDONALD SYNDROME	0.04403246	1.8871056981579568
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.043923951999999995	1.882455354636479
PETERS-PLUS SYNDROME; PTRPLS	0.043584712000000005	1.8679164954166425
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.043478300000000004	1.863355980479426
BENT BONE DYSPLASIA SYNDROME; BBDS	0.043478300000000004	1.863355980479426
MEIER-GORLIN SYNDROME 1; MGORS1	0.04307075	1.8458895494127925
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.042952782	1.840833777261968
CHARGE SYNDROME	0.042942209999999995	1.8403806914829557
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.042942209999999995	1.8403806914829557
BEEMER LETHAL MALFORMATION SYNDROME	0.042707260000000004	1.8303114043302007
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.042535712	1.8229593461370497
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.042535712	1.8229593461370497
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.04251058199999999	1.8218823459831919
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.04251058199999999	1.8218823459831919
ROBERTS SYNDROME; RBS	0.04208618000000001	1.8036936862419557
JOHANSON-BLIZZARD SYNDROME; JBS	0.04187498	1.794642256377465
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.041781450000000005	1.7906338272334041
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.041666699999999994	1.7857159693879954
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.041666699999999994	1.7857159693879954
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.041666699999999994	1.7857159693879954
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.041666699999999994	1.7857159693879954
OTOSCLEROSIS 4	0.041666699999999994	1.7857159693879954
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.041666699999999994	1.7857159693879954
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.041666699999999994	1.7857159693879954
DUANE-RADIAL RAY SYNDROME; DRRS	0.04132211	1.7709478244211176
COWDEN SYNDROME 5; CWS5	0.0412548	1.7680631097233013
COWDEN SYNDROME 6; CWS6	0.0412548	1.7680631097233013
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.041121332000000003	1.7623430517632932
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.04100009	1.7571469653067093
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.04078034	1.7477291068184435
DEAFNESS, X-LINKED 2	0.04059579	1.7398198199742598
BARAITSER-WINTER SYNDROME 2; BRWS2	0.03995744	1.712461958923137
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.03972458	1.702482243211749
BRACHYDACTYLY, TYPE B1	0.03972458	1.702482243211749
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.039305382	1.6845166120738015
CINCA SYNDROME; CINCA	0.03912402	1.6767439538205648
THUMBS, CONGENITAL CLASPED	0.0384757	1.6489588069941152
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.6483502354786053
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.6483502354786053
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.6483502354786053
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.6483502354786053
BETHLEM MYOPATHY 1	0.0384615	1.6483502354786053
ARTERIES, ANOMALIES OF	0.0384615	1.6483502354786053
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.6483502354786053
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	1.6483502354786053
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.6483502354786053
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.6483502354786053
THUMB DEFORMITY	0.0384615	1.6483502354786053
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.6483502354786053
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.6483502354786053
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.6483502354786053
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.6483502354786053
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.6483502354786053
WATSON SYNDROME	0.0384615	1.6483502354786053
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.038192772	1.6368333195476168
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.03817702	1.6361582337368903
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.038046619999999996	1.6305696615099514
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.037941092	1.6260470322924332
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.037918782	1.6250908892986984
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.037858291999999995	1.6224984603569228
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.03782037	1.6208732315533187
OROFACIODIGITAL SYNDROME VI	0.037734382	1.6171880310268612
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.03705982	1.5882782268968894
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.036988962	1.5852414550344935
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.036843310000000004	1.5789992255713179
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.03680556	1.577381368197338
#123150 JACKSON-WEISS SYNDROME; JWS;;CRANIOSYNOSTOSIS, MIDFACIAL HYPOPLASIA, AND FOOT ABNORMALITIES	0.0365853	1.5679416525630934
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.036486492	1.5637070233867174
WARSAW BREAKAGE SYNDROME; WABS	0.036014302000000005	1.5434703062100439
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.03585856	1.5367956481136638
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03585856	1.5367956481136638
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.03585856	1.5367956481136638
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.03576928199999999	1.5329694475670637
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.03573465	1.5314852187836026
TEMPLE SYNDROME	0.03572395	1.5310266472895209
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.03552319	1.522422646060378
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0354259	1.5182530740361535
ZTTK SYNDROME; ZTTKS	0.035277722000000004	1.5119025874146554
Myhre syndrome	0.03517042	1.507303929614847
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.035104572	1.5044818720688389
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.034675792	1.4861055837293689
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.03412304	1.4624162089166013
SCLEROSTEOSIS 2; SOST2	0.0340433	1.4589987798569686
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0340433	1.4589987798569686
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0340433	1.4589987798569686
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0340054	1.4573744939106419
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.03383778	1.4501907785986825
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.03379453	1.4483372069053153
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.03379453	1.4483372069053153
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03379453	1.4483372069053153
%608572 BURN-MCKEOWN SYNDROME	0.03373599	1.4458283494040498
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.033691412	1.4439178634168375
PALLISTER-KILLIAN SYNDROME	0.03334466	1.4290570612938658
CRI-DU-CHAT SYNDROME	0.033136070000000004	1.4201174885882126
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.033052512	1.4165364309337758
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.032435982	1.3901137128733876
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.032435981999999995	1.3901137128733874
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.032435981999999995	1.3901137128733874
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.032422391999999994	1.3895312842187546
15q26 overgrowth syndrome	0.032283530000000005	1.3835800547971508
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.03214214	1.377520482502926
BRACHYDACTYLY, TYPE A2; BDA2	0.03214214	1.377520482502926
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.032134131999999996	1.3771772824538973
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.032093882	1.3754522822074688
CREE MENTAL RETARDATION SYNDROME	0.032093882	1.3754522822074688
ACROCRANIOFACIAL DYSOSTOSIS	0.03195944	1.3696904813843545
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.031644602	1.3561974223139175
COSTELLO SYNDROME; CSTLO	0.031502482	1.3501065643009376
LATHOSTEROLOSIS	0.0314546	1.3480544782934967
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0314546	1.3480544782934967
#613285 DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	0.03125	1.3392859056122721
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.03125	1.3392859056122721
DEAFNESS, AUTOSOMAL DOMINANT 70	0.03125	1.3392859056122721
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.03125	1.3392859056122721
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.03125	1.3392859056122721
POPLITEAL PTERYGIUM SYNDROME	0.03125	1.3392859056122721
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03125	1.3392859056122721
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.03125	1.3392859056122721
USHER SYNDROME, TYPE IV; USH4	0.03125	1.3392859056122721
FLYNN-AIRD SYNDROME	0.03125	1.3392859056122721
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.03125	1.3392859056122721
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.03125	1.3392859056122721
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.03125	1.3392859056122721
#615540 DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76	0.03125	1.3392859056122721
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.03125	1.3392859056122721
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.03125	1.3392859056122721
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.03125	1.3392859056122721
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03125	1.3392859056122721
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.03125	1.3392859056122721
PSEUDOTRISOMY 13 SYNDROME	0.031221270000000002	1.3380546197220886
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.031218130000000004	1.3379200482742926
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.031180661999999998	1.336314276616325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.031146881999999997	1.3348665621237943
COACH SYNDROME	0.031146881999999997	1.3348665621237943
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.031146881999999997	1.3348665621237943
CURRARINO SYNDROME	0.031146881999999997	1.3348665621237943
Mulchandani-Bhoj-Conlin syndrome	0.031101610000000002	1.3329263332751906
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.031076162000000004	1.3318357045479579
RECOMBINANT CHROMOSOME 8 SYNDROME	0.031009362	1.328972846996121
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.030972051999999996	1.327373846767692
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.030789642000000002	1.3195562742223248
MEND SYNDROME; MEND	0.030789642000000002	1.3195562742223248
BAND HETEROTOPIA; BH	0.030702082	1.3158037022576716
TELANGIECTASIA, HEREDITARY BENIGN	0.030302999999999997	1.2987001855285978
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	1.2987001855285978
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.030302999999999997	1.2987001855285978
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	1.2987001855285978
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	1.2987001855285978
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030302999999999997	1.2987001855285978
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.030302999999999997	1.2987001855285978
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.030302999999999997	1.2987001855285978
CAROLI DISEASE, ISOLATED	0.030302999999999997	1.2987001855285978
AREDYLD	0.030302999999999997	1.2987001855285978
EAR FOLDING	0.030302999999999997	1.2987001855285978
DARWINIAN POINT OF PINNA	0.030302999999999997	1.2987001855285978
EAR MALFORMATION	0.030302999999999997	1.2987001855285978
OSTEOMA OF MIDDLE EAR	0.030302999999999997	1.2987001855285978
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.030302999999999997	1.2987001855285978
Polyarteritis nodosa, childhood-onset	0.030302999999999997	1.2987001855285978
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	1.2987001855285978
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.030302999999999997	1.2987001855285978
VASCULAR HYALINOSIS	0.030302999999999997	1.2987001855285978
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.030302999999999997	1.2987001855285978
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.030302999999999997	1.2987001855285978
OSSIFIED EAR CARTILAGES	0.030302999999999997	1.2987001855285978
FRYNS MICROPHTHALMIA SYNDROME	0.030302999999999997	1.2987001855285978
OTOONYCHOPERONEAL SYNDROME	0.030302999999999997	1.2987001855285978
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.030302999999999997	1.2987001855285978
MUSICAL PERFECT PITCH	0.030302999999999997	1.2987001855285978
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.030302999999999997	1.2987001855285978
BLAU SYNDROME	0.030302999999999997	1.2987001855285978
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.030302999999999997	1.2987001855285978
EAR WAX, WET/DRY	0.030302999999999997	1.2987001855285978
HAIRY EARS, Y-LINKED	0.030302999999999997	1.2987001855285978
CHEILITIS GLANDULARIS	0.030302999999999997	1.2987001855285978
SENIOR-LOKEN SYNDROME 8; SLSN8	0.030302999999999997	1.2987001855285978
EAR WITHOUT HELIX	0.030302999999999997	1.2987001855285978
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.030302999999999997	1.2987001855285978
ROIFMAN SYNDROME; RFMN	0.030279531999999998	1.2976944139563447
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.03017909	1.2933897561985364
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.03017909	1.2933897561985364
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.029928922	1.2826682689526099
HAMAMY SYNDROME; HMMS	0.02992562	1.2825267546466792
C SYNDROME	0.029664102	1.271318838759834
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02944377	1.2618760374108624
TYSHCHENKO SYNDROME	0.029126102	1.2482616926088133
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.029009082000000002	1.2432465490352214
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029004021999999997	1.2430296918613843
SMITH-MAGENIS SYNDROME; SMS	0.028924702	1.2396302628043232
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.028844332000000004	1.2361858337408336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.028668432	1.228647261235323
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.028587502	1.2251788321684045
ATELOSTEOGENESIS, TYPE I; AO1	0.028282219999999997	1.2120953160136163
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.028282219999999997	1.2120953160136163
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.02821024	1.2090104584300656
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.028177902	1.2076245439463635
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.0281652	1.2070801724400246
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.028083152	1.203563829080547
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.02787402	1.1946010278001467
ADAMS-OLIVER SYNDROME 1; AOS1	0.027647532	1.1848943978420567
FACIOCARDIORENAL SYNDROME	0.02754471	1.1804877400696772
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.02743867	1.175943167991881
WARBURG MICRO SYNDROME 3; WARBM3	0.027372179999999996	1.1730935961562277
PEHO-LIKE SYNDROME; PEHOL	0.027230551999999998	1.1670238238605462
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.027230551999999998	1.1670238238605462
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.027144522	1.163336823333832
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.027079612	1.1605549657935663
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0269171	1.1535901647985949
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.026799840000000002	1.1485647355092479
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.02657135	1.1387723055389007
ADAMS-OLIVER SYNDROME 3; AOS3	0.026509592000000002	1.1361255337322191
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.02647575	1.1346751620964517
JOUBERT SYNDROME 2	0.026399442000000002	1.131404818772117
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.026386669999999997	1.1308574472653494
GAUCHER DISEASE, PERINATAL LETHAL	0.026378549999999997	1.1305094472156352
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.02617141	1.1216320173760024
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.026018480000000004	1.1150778735825535
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.02597035	1.1130151590021655
CAMPOMELIC DYSPLASIA	0.02589276	1.109689872812839
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.02589276	1.109689872812839
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.02570207	1.1015174430739203
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.02566571	1.0999591571370224
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.025624680000000004	1.09820072831439
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.025610672	1.0976003853714837
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.025585282	1.0965122423588918
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.02555556	1.0952384421769203
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.025530820000000003	1.0941781563111652
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.025489251999999997	1.0923966703423813
FRANK-TER HAAR SYNDROME; FTHS	0.025417920000000004	1.0893395841913693
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.025329011999999998	1.0855292407898913
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.02529584	1.0841075834439404
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.025234082	1.0814608116372588
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.025080242	1.0748676678382383
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.024229862	1.0384228054889721
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.024129962000000005	1.034141376305911
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.024068810000000003	1.031520575931511
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.023993432	1.028290089755727
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.023943342	1.0261433751633393
HAREL-YOON SYNDROME; HAYOS	0.023892662000000002	1.0239713748530535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023892662000000002	1.0239713748530535
ABLEPHARON-MACROSTOMIA SYNDROME	0.02388208	1.0235178605025514
PRADER-WILLI SYNDROME; PWS	0.023773492	1.0188640884091553
BRANCHIOOCULOFACIAL SYNDROME	0.02371107	1.0161888594555513
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.023626599999999998	1.0125687160812449
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.023587711999999997	1.0109020872717267
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.023587711999999997	1.0109020872717267
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.023480932	1.0063258009036857
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.02345698	1.0052992864713264
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.02337783	1.0019071431295918
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.023352662	1.0008285144040734
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.023338662000000003	1.0002285143183594
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.023099460000000002	0.9899769985681426
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.023099460000000002	0.9899769985681426
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.023099460000000002	0.9899769985681426
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.02304878	0.9878049982578568
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.02304878	0.9878049982578568
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022952729999999998	0.9836885690983668
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022952729999999998	0.9836885690983668
OROFACIODIGITAL SYNDROME IX; OFD9	0.022952692	0.9836869405267058
HARTSFIELD SYNDROME; HRTFDS	0.022789072	0.9766746538106648
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.022712072000000003	0.9733746533392363
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.022535712	0.9658163665451951
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.022535712	0.9658163665451951
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.022535712	0.9658163665451951
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.022527592	0.9654683664954808
COFFIN-SIRIS SYNDROME 3; CSS3	0.022456592	0.9624255089179298
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.022456592	0.9624255089179298
COFFIN-SIRIS SYNDROME 4; CSS4	0.022456592	0.9624255089179298
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0224011	0.9600472800067542
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.022205422	0.9516610788087255
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.022205422	0.9516610788087255
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.022164769999999997	0.949918849988407
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02215233	0.9493857070551011
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.02210881	0.9475205639315091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.022069922	0.9458539351219906
POPOV-CHANG SYNDROME; POPCHAS	0.022025402	0.9439459348494192
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.021868190000000003	0.9372082767440396
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.021727192000000003	0.931165504452215
Diamond-Blackfan anemia 1	0.02168371	0.9293019899002842
PALLISTER-HALL SYNDROME	0.021677182	0.9290222184317455
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0216612	0.9283372754767535
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0216612	0.9283372754767535
FANCONI ANEMIA	0.02161271	0.926259132322733
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.02161271	0.926259132322733
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.02161271	0.926259132322733
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.021436562000000003	0.918709931244276
COFFIN-SIRIS SYNDROME 2; CSS2	0.021436562	0.9187099312442758
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.02136154	0.9154947022135288
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.02136154	0.9154947022135288
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.02136154	0.9154947022135288
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.021344630000000003	0.914769987824284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02127551	0.9118077016868145
KAGAMI-OGATA SYNDROME	0.021252082	0.9108036444005205
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.021252082	0.9108036444005205
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021252082	0.9108036444005205
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.021252082	0.9108036444005205
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.021252082	0.9108036444005205
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.021252082	0.9108036444005205
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.021252082	0.9108036444005205
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.021252082	0.9108036444005205
#278250 WRINKLY SKIN SYNDROME; WSS	0.02099099	0.8996139856591407
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.020913002	0.8962716423245204
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.020843882	0.893309356187051
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.020843882	0.893309356187051
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.020843882	0.893309356187051
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.020843882	0.893309356187051
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.020843882	0.893309356187051
BAKER-GORDON SYNDROME; BAGOS	0.020843882	0.893309356187051
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.020843882	0.893309356187051
JOUBERT SYNDROME 1	0.020843882	0.893309356187051
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.020843882	0.893309356187051
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.0208333	0.8928558418365488
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0208333	0.8928558418365488
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0208333	0.8928558418365488
SYNPOLYDACTYLY 2	0.0208333	0.8928558418365488
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.020794411999999998	0.8911892130270302
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.020794411999999998	0.8911892130270302
MENTAL RETARDATION, X-LINKED 98; MRX98	0.020794411999999998	0.8911892130270302
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.020794411999999998	0.8911892130270302
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.020794411999999998	0.8911892130270302
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.020794411999999998	0.8911892130270302
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.020794411999999998	0.8911892130270302
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.020794411999999998	0.8911892130270302
ANGELMAN SYNDROME	0.020794411999999998	0.8911892130270302
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.020669680000000003	0.8858435551205079
SUMMITT SYNDROME	0.020669680000000003	0.8858435551205079
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.02066895	0.8858122694017527
DUBOWITZ SYNDROME	0.020550810000000003	0.8807491258213038
LISSENCEPHALY 1; LIS1	0.020464121999999998	0.8770339252905607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.020464121999999998	0.8770339252905607
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.020464121999999998	0.8770339252905607
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.020464121999999998	0.8770339252905607
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	0.8765007823572547
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	0.8746372678053239
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	0.8746372678053239
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	0.8746372678053239
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	0.8746372678053239
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	0.8746372678053239
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	0.8746372678053239
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	0.8746372678053239
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	0.8746372678053239
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	0.8746372678053239
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	0.8746372678053239
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	0.8746372678053239
NEMALINE MYOPATHY 10	0.020408199999999998	0.8746372678053239
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	0.8746372678053239
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	0.8746372678053239
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	0.8746372678053239
184705 STEINFELD SYNDROME	0.0203372	0.8715944102277727
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.020093571999999997	0.8611532087361725
HYPOPHOSPHATASIA, CHILDHOOD	0.020069120000000003	0.8601052657293237
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.020055112	0.8595049227864174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.020055112	0.8595049227864174
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.020055112	0.8595049227864174
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.02	0.8571429795918541
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.02	0.8571429795918541
HYPOPHOSPHATASIA, ADULT	0.02	0.8571429795918541
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.02	0.8571429795918541
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.02	0.8571429795918541
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.02	0.8571429795918541
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.02	0.8571429795918541
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.02	0.8571429795918541
EXOSTOSES, MULTIPLE, TYPE I	0.02	0.8571429795918541
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.02	0.8571429795918541
MYOPATHY, DISTAL 3	0.02	0.8571429795918541
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.02	0.8571429795918541
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.02	0.8571429795918541
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.02	0.8571429795918541
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.02	0.8571429795918541
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.02	0.8571429795918541
WARBURG MICRO SYNDROME 2; WARBM2	0.019950529999999998	0.8550228364318336
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.019950529999999998	0.8550228364318336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.019950529999999998	0.8550228364318336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.019950529999999998	0.8550228364318336
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019950529999999998	0.8550228364318336
COFFIN-SIRIS SYNDROME 6; CSS6	0.019949862	0.8549942078563154
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.01968645	0.843705120529303
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.01964226	0.8418112631158948
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.019620239999999997	0.840867548695364
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.840334405762058
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.840334405762058
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.840334405762058
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.840334405762058
RAYNAUD DISEASE	0.0196078	0.840334405762058
VAN DEN BOSCH SYNDROME	0.0196078	0.840334405762058
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.840334405762058
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.840334405762058
THROMBOCYTOPENIA 3	0.0196078	0.840334405762058
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.840334405762058
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.840334405762058
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.840334405762058
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.840334405762058
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.840334405762058
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.840334405762058
TRACHEOBRONCHOMEGALY	0.0196078	0.840334405762058
HHHH SYNDROME	0.0196078	0.840334405762058
PUBIC BONE DYSPLASIA	0.0196078	0.840334405762058
MEGAEPIPHYSEAL DWARFISM	0.0196078	0.840334405762058
VESICOURETERAL REFLUX 1	0.0196078	0.840334405762058
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.840334405762058
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.840334405762058
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.840334405762058
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.840334405762058
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.840334405762058
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.840334405762058
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.840334405762058
NEPHROSIALIDOSIS	0.0196078	0.840334405762058
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	0.840334405762058
LETTERER-SIWE DISEASE	0.0196078	0.840334405762058
CARPAL DISPLACEMENT	0.0196078	0.840334405762058
MONOPHALANGY OF GREAT TOE	0.0196078	0.840334405762058
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.840334405762058
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.840334405762058
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.840334405762058
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.840334405762058
#215300 CHONDROSARCOMA	0.0196078	0.840334405762058
KNUCKLE PADS	0.0196078	0.840334405762058
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.840334405762058
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.840334405762058
SPINAL ARACHNOIDITIS	0.0196078	0.840334405762058
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	0.840334405762058
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	0.840334405762058
TOE, MISSHAPEN	0.0196078	0.840334405762058
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.019568862	0.8386656340950905
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.019459999999999998	0.8340001191428741
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.019339622	0.8288410612630087
MICROPHTHALMIA, SYNDROMIC 1	0.019254800000000002	0.8252058321722618
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.01921123	0.8233385461912207
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.019118952	0.819383774197682
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01901982	0.8151352593050369
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.8086244012320573
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.8086244012320573
MYOPATHY, CONGENITAL	0.0188679	0.8086244012320573
CARDIAC ARRHYTHMIA	0.0188679	0.8086244012320573
JUMPING FRENCHMAN OF MAINE	0.0188679	0.8086244012320573
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.8086244012320573
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.8086244012320573
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.8086244012320573
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.8086244012320573
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.8086244012320573
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.8086244012320573
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.8086244012320573
TRANSSEXUALITY	0.0188679	0.8086244012320573
MOTION SICKNESS	0.0188679	0.8086244012320573
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.8086244012320573
CERVICAL RIB	0.0188679	0.8086244012320573
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.8086244012320573
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.8086244012320573
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.8086244012320573
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.8086244012320573
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.8086244012320573
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.8086244012320573
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.8086244012320573
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	0.8086244012320573
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	0.8086244012320573
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.8086244012320573
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.8086244012320573
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.8086244012320573
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.8086244012320573
RHEUMATOID ARTHRITIS	0.0188679	0.8086244012320573
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.8086244012320573
PALMOMENTAL REFLEX	0.0188679	0.8086244012320573
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.8086244012320573
ALCOHOL DEPENDENCE	0.0188679	0.8086244012320573
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.8086244012320573
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.8086244012320573
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.8086244012320573
DIASTEMATOMYELIA	0.0188679	0.8086244012320573
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.8086244012320573
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.8086244012320573
ERYTHERMALGIA, PRIMARY	0.0188679	0.8086244012320573
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.8086244012320573
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.8086244012320573
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.8086244012320573
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.8086244012320573
269800 SENILE PLAQUE FORMATION	0.0188679	0.8086244012320573
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.8086244012320573
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.018823172000000003	0.8067074866724983
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.018818061999999997	0.8064884866412122
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.018818061999999997	0.8064884866412122
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.018818061999999997	0.8064884866412122
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.01877105	0.8044736863533839
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01874742	0.803460971922996
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01872498	0.8024992574998939
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.01872498	0.8024992574998939
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.018562581999999998	0.7955393422199059
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01849574	0.792674684667812
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.018478092	0.7919183417026203
BOHRING-OPITZ SYNDROME	0.018467992000000003	0.7914854844979264
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.01841926	0.7893969699138528
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.018387782000000002	0.7880479125782732
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018313812	0.7848777692682527
MOEBIUS SYNDROME; MBS	0.01823477	0.7814902544986078
TURNPENNY-FRY SYNDROME; TPFS	0.018176592	0.7789969112852729
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.018092212	0.775380625054375
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.01794221	0.7689519669931381
LARSEN-LIKE SYNDROME	0.017941612	0.7689263384180482
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.017820370000000002	0.7637302519614646
CEREBROOCULONASAL SYNDROME	0.01775066	0.7607426801060971
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.017737032	0.7601586228798032
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.017718699999999997	0.7593729656247092
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.017689762	0.7581327654475379
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.017624110000000002	0.7553191079027297
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.017624110000000002	0.7553191079027297
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.0175439	0.7518815359830766
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0175439	0.7518815359830766
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0175439	0.7518815359830766
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0175439	0.7518815359830766
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0175439	0.7518815359830766
TRISOMY 18-LIKE SYNDROME	0.0175439	0.7518815359830766
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0175439	0.7518815359830766
PEHO SYNDROME; PEHO	0.017510582	0.7504536214933745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.017510582	0.7504536214933745
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.017510582	0.7504536214933745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.017510582	0.7504536214933745
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.017510582	0.7504536214933745
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.017510582	0.7504536214933745
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.017510582	0.7504536214933745
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.017510582	0.7504536214933745
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.017510582	0.7504536214933745
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.017510582	0.7504536214933745
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.017510582	0.7504536214933745
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.017510582	0.7504536214933745
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.017510582	0.7504536214933745
BLOOM SYNDROME	0.017502030000000002	0.7500871071553011
HEMIFACIAL MICROSOMIA	0.01744588	0.7476806782400969
CODAS SYNDROME	0.017429042	0.7469590495655785
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.017378730000000002	0.7448028206861173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.017363272	0.7441403348771907
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.01733271	0.7428305346900764
KBG SYNDROME	0.017305382	0.7416593345227621
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.017305382	0.7416593345227621
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.017305382	0.7416593345227621
Orofaciodigital syndrome XVII	0.01724833	0.7392142484591783
#156550 KNIEST DYSPLASIA	0.017219810000000002	0.7379919625702804
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01712996	0.7341412477344639
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.01709773	0.7327599618228516
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.01709773	0.7327599618228516
ZUNICH NEUROECTODERMAL SYNDROME	0.01709773	0.7327599618228516
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.017044792	0.7304911900701699
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.016904712000000002	0.7244877606411088
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.016901470000000002	0.7243488177641169
CRANIOSYNOSTOSIS 6; CRS6	0.016859022	0.7225296175042312
CHROMOSOME 16p13.2 DELETION SYNDROME	0.016669732	0.714417187773884
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0166667	0.7142872448981777
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0166667	0.7142872448981777
Trichothiodystrophy 5, nonphotosensitive	0.0166667	0.7142872448981777
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0166667	0.7142872448981777
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0166667	0.7142872448981777
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0166667	0.7142872448981777
RETT SYNDROME, CONGENITAL VARIANT	0.0166667	0.7142872448981777
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.0166667	0.7142872448981777
SHASHI-PENA SYNDROME; SHAPNS	0.016461522	0.7054939007848429
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.0164615	0.7054929579275654
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0163486	0.7006543858077694
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0163486	0.7006543858077694
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.01626391	0.6970248138606876
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.016119412	0.6908320415474345
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.016119412	0.6908320415474345
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.016119412	0.6908320415474345
Retinitis pigmentosa with or without skeletal anomalies	0.016087762	0.6894756127822304
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.016087762	0.6894756127822304
FRONTONASAL DYSPLASIA 1; FND1	0.0160572	0.6881658125951161
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.016029872	0.6869946124278018
Aarskog-Scott syndrome	0.016029872	0.6869946124278018
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.016029872	0.6869946124278018
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.01591852	0.6822223831746261
3MC SYNDROME 2	0.015832282000000003	0.6785264683609241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.015832282000000003	0.6785264683609241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.015769282	0.6758264679752096
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.015769282	0.6758264679752096
WEBB-DATTANI SYNDROME; WEDAS	0.015769282	0.6758264679752096
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.015769282	0.6758264679752096
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.015769282	0.6758264679752096
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.015769282	0.6758264679752096
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.015769282	0.6758264679752096
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.015769282	0.6758264679752096
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015769282	0.6758264679752096
HYPERMANGANESEMIA WITH DYSTONIA 2	0.015769282	0.6758264679752096
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.015769282	0.6758264679752096
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.015769282	0.6758264679752096
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.015769282	0.6758264679752096
TETRALOGY OF FALLOT	0.01562596	0.6696840956691565
FIBROCHONDROGENESIS 1; FBCG1	0.01562596	0.6696840956691565
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.015592170000000002	0.6682359526051362
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.015429312	0.6612563230366176
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.015429312	0.6612563230366176
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.015429312	0.6612563230366176
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.015316139999999999	0.6564060937722991
CRANIOSYNOSTOSIS 7	0.015243880000000001	0.6533092361870337
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.01518599	0.6508282358326051
WAHAB SYNDROME	0.01518599	0.6508282358326051
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01518599	0.6508282358326051
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.01518599	0.6508282358326051
BARDET-BIEDL SYNDROME 1; BBS1	0.015160542	0.6497376071053724
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.015124952	0.6482123211731887
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.014925399999999998	0.639660091380013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014925399999999998	0.639660091380013
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.014925399999999998	0.639660091380013
RETT SYNDROME; RTT	0.014925399999999998	0.639660091380013
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.014925399999999998	0.639660091380013
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.014925399999999998	0.639660091380013
MENTAL RETARDATION, X-LINKED 1	0.014925399999999998	0.639660091380013
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.014925399999999998	0.639660091380013
#100800 ACHONDROPLASIA; ACH	0.01490135	0.6386293769470539
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.01490135	0.6386293769470539
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.014896462	0.6384198912028415
RITSCHER-SCHINZEL SYNDROME 1	0.014874022	0.6374581767797396
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.01473963	0.631698518814074
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01473963	0.631698518814074
HOLOPROSENCEPHALY 3; HPE3	0.014688252000000002	0.6294966042138006
JACOBSEN SYNDROME	0.01458301	0.6249862321408903
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01458301	0.6249862321408903
#614970 JOUBERT SYNDROME 20; JBTS20	0.014343592	0.6147254592464942
LOWRY-MACLEAN SYNDROME	0.014314492000000002	0.6134783162111881
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.014174660000000002	0.6074855153550737
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.01403014	0.6012918001845429
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.014009712	0.6004163143451878
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.013887581999999999	0.59518217074031
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.013855932000000001	0.593825741975106
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.013855932000000001	0.593825741975106
MICROHYDRANENCEPHALY; MHAC	0.013844370000000002	0.593330227618604
MEIER-GORLIN SYNDROME 6; MGORS6	0.013670080000000001	0.5858606551229508
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.013642752000000001	0.5846894549556364
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.013642752000000001	0.5846894549556364
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.013525642000000001	0.5796704542386363
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.013470610000000001	0.5773119396159914
FRONTONASAL DYSPLASIA 2; FND2	0.013470610000000001	0.5773119396159914
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.013470610000000001	0.5773119396159914
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.013470610000000001	0.5773119396159914
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.013470610000000001	0.5773119396159914
ADDUCTED THUMBS SYNDROME	0.013470610000000001	0.5773119396159914
TENORIO SYNDROME; TNORS	0.01329918	0.5699649385664198
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.013169420000000001	0.5644037949148278
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013042192000000001	0.5589511655644522
AU-KLINE SYNDROME; AUKS	0.013038982000000001	0.5588135941162278
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.013038982000000001	0.5588135941162278
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.013038982000000001	0.5588135941162278
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.013038982000000001	0.5588135941162278
CRANIOTELENCEPHALIC DYSPLASIA	0.013038982000000001	0.5588135941162278
PITT-HOPKINS SYNDROME	0.01301205	0.5576593653799093
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.012920112000000001	0.5537191648170235
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.012768749999999999	0.5472322210331744
IMMUNODEFICIENCY 23; IMD23	0.012734202	0.5457515922502275
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.012664632	0.5427700203957172
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.012656312	0.5424134489162069
SCHAAF-YANG SYNDROME; SHFYNG	0.012580422	0.5391610198801456
MENTAL RETARDATION, X-LINKED 91; MRX91	0.012580422	0.5391610198801456
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.012568860000000001	0.5386655055236437
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.012537942000000002	0.5373404481914926
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.01244678	0.5334335047762149
#602398 DESMOSTEROLOSIS	0.012369792000000001	0.5301340185905741
SHORT SYNDROME	0.012304720000000002	0.5273452181921741
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.012294620000000001	0.5269123609874802
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0121951	0.522647217521031
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0121951	0.522647217521031
CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS	0.0121951	0.522647217521031
CRANIORHINY	0.0121951	0.522647217521031
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0121951	0.522647217521031
SYMPHALANGISM, DISTAL	0.0121951	0.522647217521031
#615529 CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5	0.0121951	0.522647217521031
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.0121951	0.522647217521031
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.0121951	0.522647217521031
HYPERTELORISM, TEEBI TYPE; TBHS	0.0121951	0.522647217521031
CRANIOSYNOSTOSIS, ADELAIDE TYPE	0.0121951	0.522647217521031
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0121951	0.522647217521031
#614416 RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES;RHFCA	0.0121951	0.522647217521031
HYPOPHOSPHATASIA, INFANTILE	0.0121951	0.522647217521031
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0121951	0.522647217521031
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0121951	0.522647217521031
CRANIOSYNOSTOSIS 1	0.0121951	0.522647217521031
MUCOLIPIDOSIS III ALPHA/BETA	0.0121951	0.522647217521031
PROGNATHISM, MANDIBULAR	0.0121951	0.522647217521031
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.01213909	0.520246788606684
STICKLER SYNDROME, TYPE I	0.01189032	0.5095852156550308
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.01189032	0.5095852156550308
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.01189032	0.5095852156550308
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.011879582	0.5091250155892879
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.011879582	0.5091250155892879
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.011879582	0.5091250155892879
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.011879582	0.5091250155892879
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.011879582	0.5091250155892879
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.011879582	0.5091250155892879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0118562	0.5081229297318471
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.011839361999999999	0.5074013010573286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.011839361999999999	0.5074013010573286
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.011839361999999999	0.5074013010573286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011839361999999999	0.5074013010573286
LISSENCEPHALY 8; LIS8	0.011839361999999999	0.5074013010573286
RENPENNING SYNDROME 1; RENS1	0.011820750000000001	0.5066036438005206
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.011812429999999999	0.5062470723210102
SAUL-WILSON SYNDROME; SWILS	0.011766682	0.5042864434694919
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.011644602	0.49905444272206323
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.011644602	0.49905444272206323
WIEDEMANN-STEINER SYNDROME; WDSTS	0.011644602	0.49905444272206323
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.011644602	0.49905444272206323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.011644602	0.49905444272206323
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.011624102	0.4981758711679816
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.01157198	0.4959420708488673
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.01156366	0.49558549936935703
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.01152591	0.49396764199537746
MASA SYNDROME	0.01152591	0.49396764199537746
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.01152591	0.49396764199537746
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.01152591	0.49396764199537746
CHOPS SYNDROME; CHOPS	0.011511202000000002	0.49333729904818563
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.011465182	0.49136501305214475
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.011424572000000001	0.4896245842320835
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.011375332000000002	0.48751429821632836
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.011267880000000001	0.4829092118441731
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.011267880000000001	0.4829092118441731
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.011262432000000001	0.4826757260965323
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.011140352000000001	0.4774437253491037
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.011094282	0.4754692964956138
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.011094282	0.4754692964956138
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.011094282	0.4754692964956138
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.01101911	0.4722476388925198
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.01099548	0.4712349244621321
MOWAT-WILSON SYNDROME; MOWS	0.01099548	0.4712349244621321
CHITAYAT SYNDROME	0.0109228	0.46812006687429525
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.01080072	0.46288806612686656
BRACHYDACTYLY, TYPE A1, D	0.01080072	0.46288806612686656
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01078022	0.46200949457278495
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.010667320000000001	0.45717092245298896
CAMURATI-ENGELMANN DISEASE	0.010667320000000001	0.45717092245298896
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.010667320000000001	0.45717092245298896
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0106213	0.4551986364569481
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.010604071999999999	0.45446029349432754
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.010604071999999999	0.45446029349432754
LAMB-SHAFFER SYNDROME	0.010604071999999999	0.45446029349432754
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.010593972	0.45402743628963377
MENTAL RETARDATION, X-LINKED 103	0.010563851999999999	0.45273657896236835
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.010563851999999999	0.45273657896236835
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.010563851999999999	0.45273657896236835
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.010531450000000001	0.4513479216211317
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.010531450000000001	0.4513479216211317
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01041855	0.44650934950133564
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.01041855	0.44650934950133564
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.01041855	0.44650934950133564
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.01041855	0.44650934950133564
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.010348592	0.4435111490730213
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.010348592	0.4435111490730213
WILLIAMS-BEUREN SYNDROME; WBS	0.01029647	0.441277348753907
NAIL-PATELLA SYNDROME	0.01029647	0.441277348753907
WT LIMB-BLOOD SYNDROME	0.01029647	0.441277348753907
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.0102504	0.43930291990041714
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.0102504	0.43930291990041714
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.0102504	0.43930291990041714
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.0102504	0.43930291990041714
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.010219482000000002	0.4379778625682661
HOLOPROSENCEPHALY 11	0.009993412000000002	0.4282891468984496
OGDEN SYNDROME; OGDNS	0.009993412000000002	0.4282891468984496
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.009993412000000002	0.4282891468984496
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.009993412000000002	0.4282891468984496
CHROMOSOME 1p35 DELETION SYNDROME	0.009937822	0.42590671798667407
YOU-HOOVER-FONG SYNDROME; YHFS	0.009937822	0.42590671798667407
OPTIC ATROPHY 11; OPA11	0.009937822	0.42590671798667407
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.009937822	0.42590671798667407
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.009937822	0.42590671798667407
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.009937822	0.42590671798667407
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009871332	0.42305714615102086
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.009871332	0.42305714615102086
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.009871332	0.42305714615102086
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009871332	0.42305714615102086
CHROMOSOME 16p13.3 DELETION SYNDROME	0.009871332	0.42305714615102086
Glycosylphosphatidylinositol biosynthesis defect 18	0.009871332	0.42305714615102086
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.009871332	0.42305714615102086
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.009871332	0.42305714615102086
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.009863012	0.42270057467151073
MEHMO SYNDROME; MEHMO	0.009863012	0.42270057467151073
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009863012	0.42270057467151073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.009863012	0.42270057467151073
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009863012	0.42270057467151073
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00976019	0.418293916899131
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.009750090000000001	0.41786105969443715
TEEBI-SHALTOUT SYNDROME; TBSH	0.009750090000000001	0.41786105969443715
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.009750090000000001	0.41786105969443715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00971997	0.4165702023671718
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009689052	0.41524514503502075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.009689052	0.41524514503502075
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.009689052	0.41524514503502075
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.009689052	0.41524514503502075
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.009689052	0.41524514503502075
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00962437	0.41247305892472264
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.009607532	0.41175143025020433
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.009607531999999998	0.4117514302502043
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.009607531999999998	0.4117514302502043
3MC SYNDROME 3	0.00950471	0.40734477247782463
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009358762	0.401089857298551
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009358762	0.401089857298551
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00934579	0.40053391436198776
RHYNS SYNDROME; RHYNS	0.00934579	0.40053391436198776
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00934579	0.40053391436198776
FAMILIAL EXPANSILE OSTEOLYSIS	0.00934579	0.40053391436198776
#185800 SYMPHALANGISM, PROXIMAL, 1A; SYM1A;;SYM1;;CUSHING SYMPHALANGISM;;HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS	0.00934579	0.40053391436198776
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00934579	0.40053391436198776
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00934579	0.40053391436198776
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00934579	0.40053391436198776
#607842 AURAL ATRESIA, CONGENITAL; CAA;;AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA	0.00934579	0.40053391436198776
TREACHER COLLINS SYNDROME 2; TCS2	0.00934579	0.40053391436198776
DIAMOND-BLACKFAN ANEMIA 10	0.00934579	0.40053391436198776
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00934579	0.40053391436198776
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00934579	0.40053391436198776
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00934579	0.40053391436198776
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00934579	0.40053391436198776
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00934579	0.40053391436198776
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00934579	0.40053391436198776
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00934579	0.40053391436198776
CILIARY DYSKINESIA, PRIMARY, 33	0.00934579	0.40053391436198776
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00934579	0.40053391436198776
LATERAL MENINGOCELE SYNDROME	0.00934579	0.40053391436198776
PARAGANGLIOMAS 1	0.00934579	0.40053391436198776
AGNATHIA-OTOCEPHALY COMPLEX	0.00934579	0.40053391436198776
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00934579	0.40053391436198776
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00934579	0.40053391436198776
OTOFACIOCERVICAL SYNDROME	0.00934579	0.40053391436198776
OTOSCLEROSIS	0.00934579	0.40053391436198776
TREACHER COLLINS SYNDROME 3; TCS3	0.00934579	0.40053391436198776
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00934579	0.40053391436198776
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00934579	0.40053391436198776
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00934579	0.40053391436198776
OROFACIODIGITAL SYNDROME VIII; OFD8	0.009318462000000001	0.3993627141946735
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009318462000000001	0.3993627141946735
JOUBERT SYNDROME 17; JBTS17	0.009318462000000001	0.3993627141946735
#615665 JOUBERT SYNDROME 22; JBTS22	0.009318462000000001	0.3993627141946735
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00925594	0.39668319952617137
KEIPERT SYNDROME; KPTS	0.00925594	0.39668319952617137
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00925594	0.39668319952617137
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00925594	0.39668319952617137
DESANTO-SHINAWI SYNDROME	0.009230492	0.39559257079893867
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.009192742	0.393974713424959
HURLER SYNDROME	0.009192742	0.393974713424959
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.009149530000000001	0.39212277030325293
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.009149530000000001	0.39212277030325293
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.009149530000000001	0.39212277030325293
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.009149530000000001	0.39212277030325293
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.009149530000000001	0.39212277030325293
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00909394	0.38974034139147734
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00902745	0.3868907695558242
SECKEL SYNDROME 2; SCKL2	0.00902745	0.3868907695558242
BOWEN-CONRADI SYNDROME	0.00902745	0.3868907695558242
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00902745	0.3868907695558242
SECKEL SYNDROME 5; SCKL5	0.00902745	0.3868907695558242
SECKEL SYNDROME 1; SCKL1	0.00902745	0.3868907695558242
MICROCEPHALY-CARDIOMYOPATHY	0.00902745	0.3868907695558242
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.008917792	0.38219114031302004
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.008917792	0.38219114031302004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.008917792	0.38219114031302004
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.008830802	0.3784629969232853
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.008830802	0.3784629969232853
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.008830802	0.3784629969232853
GOLDBERG-SHPRINTZEN SYNDROME	0.008830802	0.3784629969232853
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.008830802	0.3784629969232853
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.008830802	0.3784629969232853
MENTAL RETARDATION, X-LINKED 102	0.008763650000000001	0.3755850536550077
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.008763650000000001	0.3755850536550077
XFE PROGEROID SYNDROME; XFEPS	0.008763650000000001	0.3755850536550077
XYLOSIDASE DEFICIENCY	0.00876365	0.3755850536550076
OCULOECTODERMAL SYNDROME; OES	0.008717902000000001	0.3736244248034893
#170100 PROLIDASE DEFICIENCY	0.008717902000000001	0.3736244248034893
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.008717902000000001	0.3736244248034893
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.008717902000000001	0.3736244248034893
FRIAS SYNDROME	0.008717902000000001	0.3736244248034893
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.008717902000000001	0.3736244248034893
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.008717902000000001	0.3736244248034893
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.008662312	0.3712419958917137
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.008662312	0.3712419958917137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.008662312	0.3712419958917137
CATEL-MANZKE SYNDROME; CATMANS	0.008595822	0.36839242405606054
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008595822	0.36839242405606054
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.008595822	0.36839242405606054
CHAR SYNDROME	0.008595822	0.36839242405606054
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.008595822	0.36839242405606054
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008595822	0.36839242405606054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.008595822	0.36839242405606054
LUSCAN-LUMISH SYNDROME; LLS	0.008587502	0.36803585257655036
GABRIELE-DE VRIES SYNDROME; GADEVS	0.008587502	0.36803585257655036
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.008514879999999999	0.36492348070335434
COFFIN-LOWRY SYNDROME; CLS	0.008514879999999999	0.36492348070335434
#174500 POLYDACTYLY, PREAXIAL II; PPD2;;POLYDACTYLY OF TRIPHALANGEAL THUMB;;TRIPHALANGEAL THUMB-POLYDACTYLY SYNDROMETRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, INCLUDED;;TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME, INCLUDED;;TPT-PS SYNDROME, INCLUDED;;TRIPHALANGEAL THUMB, INCLUDED; TPT, INCLUDED	0.00847458	0.3631963375994768
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00847458	0.3631963375994768
#603543 LIMB-MAMMARY SYNDROME; LMS	0.00847458	0.3631963375994768
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.00847458	0.3631963375994768
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00847458	0.3631963375994768
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00847458	0.3631963375994768
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00847458	0.3631963375994768
TUKEL SYNDROME	0.00847458	0.3631963375994768
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.00847458	0.3631963375994768
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.00847458	0.3631963375994768
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00847458	0.3631963375994768
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.00847458	0.3631963375994768
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.00847458	0.3631963375994768
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.00847458	0.3631963375994768
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00847458	0.3631963375994768
BARTSOCAS-PAPAS SYNDROME; BPS	0.00847458	0.3631963375994768
ADAMS-OLIVER SYNDROME 6; AOS6	0.00847458	0.3631963375994768
SCHIZOPHRENIA 1; SCZD1	0.00847458	0.3631963375994768
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.00847458	0.3631963375994768
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00847458	0.3631963375994768
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.00847458	0.3631963375994768
CAMPTOBRACHYDACTYLY	0.00847458	0.3631963375994768
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.00847458	0.3631963375994768
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00847458	0.3631963375994768
BARDET-BIEDL SYNDROME 6; BBS6	0.00847458	0.3631963375994768
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00847458	0.3631963375994768
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.00847458	0.3631963375994768
BARDET-BIEDL SYNDROME 4; BBS4	0.00847458	0.3631963375994768
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.00847458	0.3631963375994768
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00847458	0.3631963375994768
ADAMS-OLIVER SYNDROME 5; AOS5	0.00847458	0.3631963375994768
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00847458	0.3631963375994768
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00847458	0.3631963375994768
BARDET-BIEDL SYNDROME 5; BBS5	0.00847458	0.3631963375994768
Pontine tegmental cap dysplasia	0.008413542	0.3605804229400604
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00834886	0.3578083368297624
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00834886	0.3578083368297624
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00834886	0.3578083368297624
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00834886	0.3578083368297624
KRABBE DISEASE	0.00834886	0.3578083368297624
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00834886	0.3578083368297624
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.008332022	0.35708670815524396
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00798692	0.3422966203280886
COFFIN-SIRIS SYNDROME 10; CSS10	0.00798692	0.3422966203280886
MEIER-GORLIN SYNDROME 5; MGORS5	0.00798692	0.3422966203280886
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00798692	0.3422966203280886
SECKEL SYNDROME 7; SCKL7	0.00798692	0.3422966203280886
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00798692	0.3422966203280886
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00798692	0.3422966203280886
EMANUEL SYNDROME	0.007961472	0.34120599160085596
Pierpont syndrome	0.007961472	0.34120599160085596
PELIZAEUS-MERZBACHER DISEASE	0.007961472	0.34120599160085596
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00787402	0.3374580482082926
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00787402	0.3374580482082926
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00787402	0.3374580482082926
BECKWITH-WIEDEMANN SYNDROME	0.00787402	0.3374580482082926
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00787402	0.3374580482082926
DESBUQUOIS DYSPLASIA 1	0.00787402	0.3374580482082926
CHERUBISM	0.00787402	0.3374580482082926
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00787402	0.3374580482082926
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00787402	0.3374580482082926
LOEYS-DIETZ SYNDROME 5	0.00787402	0.3374580482082926
MELNICK-NEEDLES SYNDROME	0.00787402	0.3374580482082926
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00787402	0.3374580482082926
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00787402	0.3374580482082926
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00787402	0.3374580482082926
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00787402	0.3374580482082926
MACHADO-JOSEPH DISEASE; MJD	0.00787402	0.3374580482082926
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00787402	0.3374580482082926
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00787402	0.3374580482082926
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.00787402	0.3374580482082926
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00787402	0.3374580482082926
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.007818430000000001	0.3350756192965171
OPTICOCOCHLEODENTATE DEGENERATION	0.007818430000000001	0.3350756192965171
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00775194	0.33222604746086387
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.00775194	0.33222604746086387
TALONAVICULAR COALITION	0.00775194	0.33222604746086387
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00775194	0.33222604746086387
HAND-FOOT-GENITAL SYNDROME; HFG	0.00775194	0.33222604746086387
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00775194	0.33222604746086387
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00775194	0.33222604746086387
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00775194	0.33222604746086387
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00775194	0.33222604746086387
BRACHYDACTYLY, TYPE A3	0.00775194	0.33222604746086387
PELVIS-SHOULDER DYSPLASIA	0.00775194	0.33222604746086387
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00775194	0.33222604746086387
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.00775194	0.33222604746086387
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00775194	0.33222604746086387
WEYERS ACROFACIAL DYSOSTOSIS	0.00775194	0.33222604746086387
CLEIDORHIZOMELIC SYNDROME	0.00775194	0.33222604746086387
MOLAR I REINCLUSION	0.00775194	0.33222604746086387
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00774362	0.3318694759813537
SOTOS SYNDROME 2	0.00774362	0.3318694759813537
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00774362	0.3318694759813537
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0076749520000000005	0.328926561275223
HOLOPROSENCEPHALY 5; HPE5	0.0076749520000000005	0.328926561275223
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.0076749520000000005	0.328926561275223
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.0076749520000000005	0.328926561275223
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0076749520000000005	0.328926561275223
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0076749520000000005	0.328926561275223
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0076749520000000005	0.328926561275223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.007569660000000001	0.3244140463448638
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.007555292	0.32379827482832496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.007555292	0.32379827482832496
CHROMOSOME 18P DELETION SYNDROME	0.007555292	0.32379827482832496
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.007555292	0.32379827482832496
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007555292	0.32379827482832496
SIFRIM-HITZ-WEISS SYNDROME	0.00748814	0.32092033156004734
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007144522	0.30619384374197767
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.007144522	0.30619384374197767
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.007144522	0.30619384374197767
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.007144522	0.30619384374197767
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.007144522	0.30619384374197767
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.007144522	0.30619384374197767
Xq28 (MECP2) duplication	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.007144522	0.30619384374197767
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.007144522	0.30619384374197767
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.007144522	0.30619384374197767
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.007144522	0.30619384374197767
MUCOLIPIDOSIS IV; ML4	0.007144522	0.30619384374197767
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.007144522	0.30619384374197767
COFFIN-SIRIS SYNDROME 5	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.007144522	0.30619384374197767
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007144522	0.30619384374197767
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007144522	0.30619384374197767
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.007144522	0.30619384374197767
OROFACIODIGITAL SYNDROME XIV; OFD14	0.007144522	0.30619384374197767
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.007144522	0.30619384374197767
HADZISELIMOVIC SYNDROME	0.007144522	0.30619384374197767
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.007144522	0.30619384374197767
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.007144522	0.30619384374197767
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.007144522	0.30619384374197767
AICARDI-GOUTIERES SYNDROME 7	0.007144522	0.30619384374197767
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.007144522	0.30619384374197767
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.007144522	0.30619384374197767
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.007144522	0.30619384374197767
AL-RAQAD SYNDROME; ARS	0.007144522	0.30619384374197767
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.007144522	0.30619384374197767
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.007144522	0.30619384374197767
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007144522	0.30619384374197767
KLEEFSTRA SYNDROME	0.00711759	0.3050396150056593
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00711759	0.3050396150056593
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00711759	0.3050396150056593
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00683107	0.2927601846800264
MECKEL SYNDROME, TYPE 4; MKS4	0.00683107	0.2927601846800264
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00683107	0.2927601846800264
STROMME SYNDROME; STROMS	0.00683107	0.2927601846800264
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00683107	0.2927601846800264
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.006814232	0.292038556005508
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.006814232	0.292038556005508
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.006814232	0.292038556005508
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.006814232	0.292038556005508
SECKEL SYNDROME 9; SCKL9	0.006814232	0.292038556005508
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.006814232	0.292038556005508
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.006814232	0.292038556005508
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.006814232	0.292038556005508
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.006814232	0.292038556005508
MACDERMOT-WINTER SYNDROME	0.006814232	0.292038556005508
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.006814232	0.292038556005508
Mental retardation, autosomal dominant 21	0.006814232	0.292038556005508
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.006814232	0.292038556005508
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.006814232	0.292038556005508
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.006814232	0.292038556005508
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.006814232	0.292038556005508
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.006814232	0.292038556005508
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.006814232	0.292038556005508
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.006814232	0.292038556005508
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.006814232	0.292038556005508
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.006814232	0.292038556005508
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.006814232	0.292038556005508
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00671141	0.28763189823312835
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00671141	0.28763189823312835
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00671141	0.28763189823312835
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00671141	0.28763189823312835
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	0.28763189823312835
MCDONOUGH SYNDROME	0.00671141	0.28763189823312835
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00671141	0.28763189823312835
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00671141	0.28763189823312835
109300 BANKI SYNDROME	0.00671141	0.28763189823312835
RUIJS-AALFS SYNDROME; RJALS	0.00671141	0.28763189823312835
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00671141	0.28763189823312835
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00671141	0.28763189823312835
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00671141	0.28763189823312835
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.00671141	0.28763189823312835
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00671141	0.28763189823312835
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00671141	0.28763189823312835
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00671141	0.28763189823312835
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00671141	0.28763189823312835
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00671141	0.28763189823312835
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00671141	0.28763189823312835
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00671141	0.28763189823312835
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.006685962	0.28654126950589565
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.0066133400000000005	0.2834288976326997
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0064371920000000004	0.2758796965542424
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0064371920000000004	0.2758796965542424
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0064371920000000004	0.2758796965542424
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0064371920000000004	0.2758796965542424
GALACTOSE EPIMERASE DEFICIENCY	0.0064371920000000004	0.2758796965542424
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0064371920000000004	0.2758796965542424
NOONAN SYNDROME 6; NS6	0.0064371920000000004	0.2758796965542424
MELANOSIS, NEUROCUTANEOUS; NCMS	0.006399442	0.2742618391802627
JOUBERT SYNDROME 14	0.006399442	0.2742618391802627
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.006399442	0.2742618391802627
CHROMOSOME 17P13.1 DELETION SYNDROME	0.006399442	0.2742618391802627
HOLOPROSENCEPHALY 7	0.006399442	0.2742618391802627
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.006399442	0.2742618391802627
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.006399442	0.2742618391802627
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006399442	0.2742618391802627
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.006399442	0.2742618391802627
MIRAGE SYNDROME; MIRAGE	0.006399442	0.2742618391802627
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.006399442	0.2742618391802627
GRACILE BONE DYSPLASIA; GCLEB	0.006399442	0.2742618391802627
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00630064	0.270027467146781
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00630064	0.270027467146781
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00630064	0.270027467146781
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00630064	0.270027467146781
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00630064	0.270027467146781
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00630064	0.270027467146781
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00630064	0.270027467146781
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00630064	0.270027467146781
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00630064	0.270027467146781
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00630064	0.270027467146781
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00630064	0.270027467146781
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00630064	0.270027467146781
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00630064	0.270027467146781
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00630064	0.270027467146781
RICHARDS-RUNDLE SYNDROME; RRNS	0.006181712000000001	0.26493055213293604
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.005970349999999999	0.2558721794103113
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.005970349999999999	0.2558721794103113
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.005970349999999999	0.2558721794103113
LISSENCEPHALY 3; LIS3	0.005970349999999999	0.2558721794103113
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.005970349999999999	0.2558721794103113
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.005970349999999999	0.2558721794103113
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.005970349999999999	0.2558721794103113
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.005970349999999999	0.2558721794103113
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.005970349999999999	0.2558721794103113
PSEUDO-TORCH SYNDROME 2	0.005970349999999999	0.2558721794103113
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.005970349999999999	0.2558721794103113
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.005970349999999999	0.2558721794103113
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.005970349999999999	0.2558721794103113
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.005869012	0.25152912164701735
RAYNAUD-CLAES SYNDROME; MRXSRC	0.005869012	0.25152912164701735
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.005869012	0.25152912164701735
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.005869012	0.25152912164701735
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.005869012	0.25152912164701735
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005869012	0.25152912164701735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005869012	0.25152912164701735
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005869012	0.25152912164701735
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.005869012	0.25152912164701735
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.005869012	0.25152912164701735
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005869012	0.25152912164701735
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005869012	0.25152912164701735
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005869012	0.25152912164701735
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.005869012	0.25152912164701735
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005869012	0.25152912164701735
JOUBERT SYNDROME 24	0.005869012	0.25152912164701735
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.005869012	0.25152912164701735
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.005869012	0.25152912164701735
IMMUNODEFICIENCY 49; IMD49	0.005869012	0.25152912164701735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.005869012	0.25152912164701735
MENTAL RETARDATION, X-LINKED 101; MRX101	0.005869012	0.25152912164701735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005869012	0.25152912164701735
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005869012	0.25152912164701735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.005869012	0.25152912164701735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005869012	0.25152912164701735
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.005869012	0.25152912164701735
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.005869012	0.25152912164701735
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.005869012	0.25152912164701735
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.005869012	0.25152912164701735
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.00584208	0.250374892910699
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00584208	0.250374892910699
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.005593310000000001	0.2397133199590457
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.005593310000000001	0.2397133199590457
THORACOABDOMINAL SYNDROME	0.00555556	0.23809546258506611
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00555556	0.23809546258506611
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00555556	0.23809546258506611
RADIAL APLASIA, X-LINKED	0.00555556	0.23809546258506611
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00555556	0.23809546258506611
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00555556	0.23809546258506611
BIEMOND SYNDROME II	0.00555556	0.23809546258506611
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00555556	0.23809546258506611
ALEXANDER DISEASE	0.00555556	0.23809546258506611
BASAL CELL NEVUS SYNDROME	0.00555556	0.23809546258506611
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00555556	0.23809546258506611
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00555556	0.23809546258506611
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00555556	0.23809546258506611
AASE-SMITH SYNDROME I	0.00555556	0.23809546258506611
EDINBURGH MALFORMATION SYNDROME	0.00555556	0.23809546258506611
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00555556	0.23809546258506611
PAPILLOMA OF CHOROID PLEXUS	0.00555556	0.23809546258506611
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.00555556	0.23809546258506611
MECKEL SYNDROME, TYPE 6; MKS6	0.00555556	0.23809546258506611
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00555556	0.23809546258506611
NEPHRONOPHTHISIS 18; NPHP18	0.00555556	0.23809546258506611
GAUCHER DISEASE, TYPE IIIC	0.00555556	0.23809546258506611
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00555556	0.23809546258506611
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00555556	0.23809546258506611
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00555556	0.23809546258506611
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00555556	0.23809546258506611
CHIARI MALFORMATION TYPE II	0.00555556	0.23809546258506611
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.00555556	0.23809546258506611
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.00555556	0.23809546258506611
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00555556	0.23809546258506611
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00555556	0.23809546258506611
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00555556	0.23809546258506611
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.00555556	0.23809546258506611
NEUROFIBROMATOSIS, TYPE I	0.00555556	0.23809546258506611
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00555556	0.23809546258506611
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00555556	0.23809546258506611
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00555556	0.23809546258506611
MEGALENCEPHALY	0.00555556	0.23809546258506611
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00555556	0.23809546258506611
DANDY-WALKER SYNDROME	0.00555556	0.23809546258506611
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.005538721999999999	0.23737383391054767
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.005538721999999999	0.23737383391054767
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.005538721999999999	0.23737383391054767
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.005538721999999999	0.23737383391054767
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.005538721999999999	0.23737383391054767
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005538721999999999	0.23737383391054767
ROIFMAN-CHITAYAT SYNDROME	0.005538721999999999	0.23737383391054767
OROFACIODIGITAL SYNDROME XVI; OFD16	0.005538721999999999	0.23737383391054767
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005538721999999999	0.23737383391054767
JOUBERT SYNDROME 31; JBTS31	0.005538721999999999	0.23737383391054767
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.005538721999999999	0.23737383391054767
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.005538721999999999	0.23737383391054767
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.005538721999999999	0.23737383391054767
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.005538721999999999	0.23737383391054767
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.005538721999999999	0.23737383391054767
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.005538721999999999	0.23737383391054767
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.005538721999999999	0.23737383391054767
AYME-GRIPP SYNDROME; AYGRP	0.00533783	0.22876417553773934
COWCHOCK SYNDROME; COWCK	0.00533783	0.22876417553773934
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00533783	0.22876417553773934
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00533783	0.22876417553773934
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00533783	0.22876417553773934
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.005168172	0.22149311735615965
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.005168172	0.22149311735615965
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.005168172	0.22149311735615965
GLASS SYNDROME	0.005168172	0.22149311735615965
WIEACKER-WOLFF SYNDROME	0.005168172	0.22149311735615965
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.005168172	0.22149311735615965
KLEEFSTRA SYNDROME 2; KLEFS2	0.005168172	0.22149311735615965
ADENYLOSUCCINASE DEFICIENCY	0.005168172	0.22149311735615965
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.005168172	0.22149311735615965
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.005168172	0.22149311735615965
TONNE-KALSCHEUER SYNDROME; TOKAS	0.005168172	0.22149311735615965
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.005168172	0.22149311735615965
#614728 SECKEL SYNDROME 6; SCKL6	0.005168172	0.22149311735615965
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.005168172	0.22149311735615965
LIG4 SYNDROME	0.005168172	0.22149311735615965
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.005168172	0.22149311735615965
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.005168172	0.22149311735615965
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.005168172	0.22149311735615965
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.005168172	0.22149311735615965
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.005168172	0.22149311735615965
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.005168172	0.22149311735615965
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.005168172	0.22149311735615965
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.005168172	0.22149311735615965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005168172	0.22149311735615965
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.005168172	0.22149311735615965
FORSYTHE-WAKELING SYNDROME; FWS	0.005168172	0.22149311735615965
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.005168172	0.22149311735615965
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.005168172	0.22149311735615965
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.005168172	0.22149311735615965
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.005168172	0.22149311735615965
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.005168172	0.22149311735615965
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00502513	0.21536274505182074
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00502513	0.21536274505182074
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00502513	0.21536274505182074
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00502513	0.21536274505182074
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.21536274505182074
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00502513	0.21536274505182074
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00502513	0.21536274505182074
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00502513	0.21536274505182074
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00502513	0.21536274505182074
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00502513	0.21536274505182074
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.004912692000000001	0.2105439729348533
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.004912692000000001	0.2105439729348533
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004912692000000001	0.2105439729348533
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.004912692000000001	0.2105439729348533
GENITOPATELLAR SYNDROME; GTPTS	0.004912692	0.21054397293485327
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.004912692	0.21054397293485327
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.004912692	0.21054397293485327
#300867 KABUKI SYNDROME 2; KABUK2	0.004912692	0.21054397293485327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.004912692	0.21054397293485327
KABUKI SYNDROME 1	0.004912692	0.21054397293485327
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004912692	0.21054397293485327
#612900 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	0.00469484	0.20120745731535103
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00469484	0.20120745731535103
LISSENCEPHALY, X-LINKED, 2	0.00469484	0.20120745731535103
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	0.00469484	0.20120745731535103
OROFACIODIGITAL SYNDROME XV; OFD15	0.00469484	0.20120745731535103
GLUTAMINE DEFICIENCY, CONGENITAL	0.00469484	0.20120745731535103
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.00469484	0.20120745731535103
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00469484	0.20120745731535103
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00469484	0.20120745731535103
MACROCEPHALY, BENIGN FAMILIAL	0.00469484	0.20120745731535103
LOWE OCULOCEREBRORENAL SYNDROME	0.00469484	0.20120745731535103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00469484	0.20120745731535103
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00469484	0.20120745731535103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00469484	0.20120745731535103
GAPO SYNDROME; GAPOS	0.00469484	0.20120745731535103
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.00469484	0.20120745731535103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00469484	0.20120745731535103
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00469484	0.20120745731535103
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00469484	0.20120745731535103
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.00469484	0.20120745731535103
COLOBOMA, OCULAR	0.00469484	0.20120745731535103
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00469484	0.20120745731535103
KNOBLOCH SYNDROME 1; KNO1	0.00469484	0.20120745731535103
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.004663922000000001	0.19988239998320004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004663922000000001	0.19988239998320004
MICROPHTHALMIA, SYNDROMIC 3	0.004663922000000001	0.19988239998320004
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.004663922000000001	0.19988239998320004
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.004663922000000001	0.19988239998320004
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004663922000000001	0.19988239998320004
VICI SYNDROME; VICIS	0.004663922000000001	0.19988239998320004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004663922000000001	0.19988239998320004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004663922000000001	0.19988239998320004
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.004663922000000001	0.19988239998320004
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.004663922000000001	0.19988239998320004
INFANTILE LIVER FAILURE SYNDROME 1	0.004663922000000001	0.19988239998320004
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.004663922000000001	0.19988239998320004
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004663922000000001	0.19988239998320004
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00432429	0.18532674076096295
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00432429	0.18532674076096295
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00432429	0.18532674076096295
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00432429	0.18532674076096295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00432429	0.18532674076096295
VERVERI-BRADY SYNDROME; VERBRAS	0.00432429	0.18532674076096295
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00432429	0.18532674076096295
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00432429	0.18532674076096295
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00432429	0.18532674076096295
GERODERMA OSTEODYSPLASTICUM; GO	0.00432429	0.18532674076096295
#615328 SHAHEEN SYNDROME; SHNS	0.00432429	0.18532674076096295
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00432429	0.18532674076096295
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00432429	0.18532674076096295
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00432429	0.18532674076096295
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.00432429	0.18532674076096295
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00432429	0.18532674076096295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00432429	0.18532674076096295
MEIER-GORLIN SYNDROME 3; MGORS3	0.00432429	0.18532674076096295
ASPARTYLGLUCOSAMINURIA; AGU	0.00432429	0.18532674076096295
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00432429	0.18532674076096295
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.004068810000000001	0.17437759633965663
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.004068810000000001	0.17437759633965663
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.004068810000000001	0.17437759633965663
CYCLIC VOMITING SYNDROME	0.004068810000000001	0.17437759633965663
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.004068810000000001	0.17437759633965663
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.004068810000000001	0.17437759633965663
Cerebral creatine deficiency syndrome 2	0.003892662	0.16682839526119933
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.003892662	0.16682839526119933
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.003892662	0.16682839526119933
MENTAL RETARDATION, X-LINKED 90	0.003892662	0.16682839526119933
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.003892662	0.16682839526119933
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.003892662	0.16682839526119933
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.003892662	0.16682839526119933
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.003892662	0.16682839526119933
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.003892662	0.16682839526119933
XQ25 DUPLICATION SYNDROME	0.003892662	0.16682839526119933
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.003892662	0.16682839526119933
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.003892662	0.16682839526119933
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003892662	0.16682839526119933
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.003892662	0.16682839526119933
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.003892662	0.16682839526119933
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.003892662	0.16682839526119933
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.003892662	0.16682839526119933
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.003892662	0.16682839526119933
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.003892662	0.16682839526119933
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.003892662	0.16682839526119933
CHROMOSOME 5Q12 DELETION SYNDROME	0.003892662	0.16682839526119933
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.003892662	0.16682839526119933
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.003892662	0.16682839526119933
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.003892662	0.16682839526119933
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.003892662	0.16682839526119933
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.003892662	0.16682839526119933
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.003892662	0.16682839526119933
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.003892662	0.16682839526119933
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.003892662	0.16682839526119933
LANDAU-KLEFFNER SYNDROME	0.003892662	0.16682839526119933
DIGEORGE SYNDROME; DGS	0.003892662	0.16682839526119933
CHROMOSOME 9P DELETION SYNDROME	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.003892662	0.16682839526119933
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003892662	0.16682839526119933
HYPERPROLINEMIA, TYPE I	0.003892662	0.16682839526119933
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003892662	0.16682839526119933
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.003892662	0.16682839526119933
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.003892662	0.16682839526119933
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.003892662	0.16682839526119933
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.003892662	0.16682839526119933
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003892662	0.16682839526119933
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.003892662	0.16682839526119933
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.003892662	0.16682839526119933
COHEN-GIBSON SYNDROME; COGIS	0.003892662	0.16682839526119933
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.003892662	0.16682839526119933
MENTAL RETARDATION, X-LINKED 9	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.003892662	0.16682839526119933
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.003892662	0.16682839526119933
SALLA DISEASE	0.003892662	0.16682839526119933
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.003892662	0.16682839526119933
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.003892662	0.16682839526119933
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003892662	0.16682839526119933
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.003892662	0.16682839526119933
SHUKLA-VERNON SYNDROME; SHUVER	0.003892662	0.16682839526119933
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.003892662	0.16682839526119933
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003892662	0.16682839526119933
Cerebral creatine deficiency syndrome 3	0.003892662	0.16682839526119933
JOUBERT SYNDROME 30; JBTS30	0.003892662	0.16682839526119933
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.003892662	0.16682839526119933
EPILEPSY, PYRIDOXINE-DEPENDENT	0.003892662	0.16682839526119933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.003892662	0.16682839526119933
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.003892662	0.16682839526119933
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.003892662	0.16682839526119933
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.003892662	0.16682839526119933
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.003892662	0.16682839526119933
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.003892662	0.16682839526119933
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.0038200400000000002	0.16371602338800334
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0038200400000000002	0.16371602338800334
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0038200400000000002	0.16371602338800334
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0038200400000000002	0.16371602338800334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.0038200400000000002	0.16371602338800334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.0038200400000000002	0.16371602338800334
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0038200400000000002	0.16371602338800334
DE SANCTIS-CACCHIONE SYNDROME	0.0038200400000000002	0.16371602338800334
KEARNS-SAYRE SYNDROME; KSS	0.0038200400000000002	0.16371602338800334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0038200400000000002	0.16371602338800334
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.003637182	0.15587925083989299
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.003637182	0.15587925083989299
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.003637182	0.15587925083989299
OCULOSKELETODENTAL SYNDROME; OCSKD	0.003637182	0.15587925083989299
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.003637182	0.15587925083989299
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.003637182	0.15587925083989299
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003637182	0.15587925083989299
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.003637182	0.15587925083989299
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.003637182	0.15587925083989299
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003637182	0.15587925083989299
HYDROXYKYNURENINURIA	0.003637182	0.15587925083989299
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003637182	0.15587925083989299
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003637182	0.15587925083989299
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.003637182	0.15587925083989299
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.003637182	0.15587925083989299
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.003637182	0.15587925083989299
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.003637182	0.15587925083989299
LYMPHEDEMA, HEREDITARY, III	0.003637182	0.15587925083989299
BARDET-BIEDL SYNDROME 16; BBS16	0.003637182	0.15587925083989299
PEROXISOME BIOGENESIS DISORDER 5B	0.0033884120000000004	0.1452176778882397
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0033884120000000004	0.1452176778882397
LEIGH SYNDROME; LS	0.0033884120000000004	0.1452176778882397
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0033884120000000004	0.1452176778882397
WAARDENBURG-SHAH SYNDROME	0.0033884120000000004	0.1452176778882397
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0033884120000000004	0.1452176778882397
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0033884120000000004	0.1452176778882397
JOUBERT SYNDROME 21	0.0033884120000000004	0.1452176778882397
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.0033884120000000004	0.1452176778882397
HYPERTRYPTOPHANEMIA; HYPTRP	0.0033884120000000004	0.1452176778882397
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0033884120000000004	0.1452176778882397
PEROXISOME BIOGENESIS DISORDER 3B	0.0033884120000000004	0.1452176778882397
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0033884120000000004	0.1452176778882397
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.0033884120000000004	0.1452176778882397
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0033884120000000004	0.1452176778882397
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.0033884120000000004	0.1452176778882397
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0033884120000000004	0.1452176778882397
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0033884120000000004	0.1452176778882397
STEEL SYNDROME; STLS	0.0033884120000000004	0.1452176778882397
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0033884120000000004	0.1452176778882397
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0033884120000000004	0.1452176778882397
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0033884120000000004	0.1452176778882397
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0033884120000000004	0.1452176778882397
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0033884120000000004	0.1452176778882397
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0033884120000000004	0.1452176778882397
NOONAN SYNDROME 11; NS11	0.0033884120000000004	0.1452176778882397
CHROMOSOME 2q37 DELETION SYNDROME	0.0033884120000000004	0.1452176778882397
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0033884120000000004	0.1452176778882397
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.0033884120000000004	0.1452176778882397
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0033884120000000004	0.1452176778882397
PEROXISOME BIOGENESIS DISORDER 6B	0.0033884120000000004	0.1452176778882397
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00304878	0.13066201866600266
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00304878	0.13066201866600266
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00304878	0.13066201866600266
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00304878	0.13066201866600266
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00304878	0.13066201866600266
COFFIN-SIRIS SYNDROME 8; CSS8	0.00304878	0.13066201866600266
HYPOGLOSSIA WITH SITUS INVERSUS	0.00304878	0.13066201866600266
8p23.1 duplication syndrome	0.00304878	0.13066201866600266
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00304878	0.13066201866600266
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00304878	0.13066201866600266
RETINITIS PIGMENTOSA 71; RP71	0.00304878	0.13066201866600266
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00304878	0.13066201866600266
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00304878	0.13066201866600266
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00304878	0.13066201866600266
224550 DYSTONIA WITH RINGBINDEN	0.00304878	0.13066201866600266
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00304878	0.13066201866600266
AUTISM	0.00304878	0.13066201866600266
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00304878	0.13066201866600266
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00304878	0.13066201866600266
BARDET-BIEDL SYNDROME 21; BBS21	0.00304878	0.13066201866600266
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00304878	0.13066201866600266
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00304878	0.13066201866600266
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00304878	0.13066201866600266
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00304878	0.13066201866600266
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.00304878	0.13066201866600266
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00304878	0.13066201866600266
MENTAL RETARDATION, X-LINKED 93	0.00304878	0.13066201866600266
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00304878	0.13066201866600266
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00304878	0.13066201866600266
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00304878	0.13066201866600266
FG SYNDROME 2; FGS2	0.00304878	0.13066201866600266
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00304878	0.13066201866600266
MENTAL RETARDATION, X-LINKED 19	0.00304878	0.13066201866600266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00304878	0.13066201866600266
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00304878	0.13066201866600266
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00304878	0.13066201866600266
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00304878	0.13066201866600266
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00304878	0.13066201866600266
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00304878	0.13066201866600266
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00304878	0.13066201866600266
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00304878	0.13066201866600266
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00304878	0.13066201866600266
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.00304878	0.13066201866600266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00304878	0.13066201866600266
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00304878	0.13066201866600266
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00304878	0.13066201866600266
DYSTONIA 16; DYT16	0.00304878	0.13066201866600266
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.00304878	0.13066201866600266
SPEECH-LANGUAGE DISORDER 1	0.00304878	0.13066201866600266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00304878	0.13066201866600266
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00304878	0.13066201866600266
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00304878	0.13066201866600266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00304878	0.13066201866600266
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00304878	0.13066201866600266
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00304878	0.13066201866600266
7q11.23 duplication syndrome	0.00304878	0.13066201866600266
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00304878	0.13066201866600266
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00304878	0.13066201866600266
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.00304878	0.13066201866600266
HYPERLYSINEMIA, TYPE I	0.00304878	0.13066201866600266
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00304878	0.13066201866600266
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00304878	0.13066201866600266
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00304878	0.13066201866600266
MENTAL RETARDATION, X-LINKED 95	0.00304878	0.13066201866600266
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00304878	0.13066201866600266
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00304878	0.13066201866600266
MAXILLOFACIAL DYSOSTOSIS	0.00304878	0.13066201866600266
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00304878	0.13066201866600266
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00304878	0.13066201866600266
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.00304878	0.13066201866600266
CHROMOSOME 13q14 DELETION SYNDROME	0.00304878	0.13066201866600266
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.11971287424469633
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.11971287424469633
COXOAURICULAR SYNDROME	0.0027933000000000003	0.11971287424469633
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0027933000000000003	0.11971287424469633
RAPADILINO SYNDROME	0.0027933000000000003	0.11971287424469633
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.11971287424469633
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.11971287424469633
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.11971287424469633
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.0027933000000000003	0.11971287424469633
DYSOSTEOSCLEROSIS	0.0027933000000000003	0.11971287424469633
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.11971287424469633
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.11971287424469633
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.11971287424469633
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.11971287424469633
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.11971287424469633
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027933000000000003	0.11971287424469633
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0027933000000000003	0.11971287424469633
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027933000000000003	0.11971287424469633
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.0027933000000000003	0.11971287424469633
CHARGE-LIKE SYNDROME, X-LINKED	0.0027933000000000003	0.11971287424469633
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.11971287424469633
MENIERE DISEASE	0.0027933000000000003	0.11971287424469633
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.11971287424469633
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.11971287424469633
HARDIKAR SYNDROME	0.0027933000000000003	0.11971287424469633
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.0027933000000000003	0.11971287424469633
Adrenoleukodystrophy	0.0027933000000000003	0.11971287424469633
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0027933000000000003	0.11971287424469633
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.11971287424469633
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.11971287424469633
DEAFNESS, X-LINKED 7; DFNX7	0.0027933000000000003	0.11971287424469633
SPASTIC PARAPARESIS AND DEAFNESS	0.0027933000000000003	0.11971287424469633
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.11971287424469633
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.11971287424469633
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.11971287424469633
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0027933000000000003	0.11971287424469633
FETAL IODINE DEFICIENCY DISORDER	0.0027933000000000003	0.11971287424469633
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0027933000000000003	0.11971287424469633
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.0027933000000000003	0.11971287424469633
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.0027933000000000003	0.11971287424469633
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.0027933000000000003	0.11971287424469633
EAR EXOSTOSES	0.0027933000000000003	0.11971287424469633
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0027933000000000003	0.11971287424469633
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.11971287424469633
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.0027933000000000003	0.11971287424469633
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.0027933000000000003	0.11971287424469633
DEAFNESS-CRANIOFACIAL SYNDROME	0.0027933000000000003	0.11971287424469633
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.11971287424469633
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027933000000000003	0.11971287424469633
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0027933000000000003	0.11971287424469633
WILDERVANCK SYNDROME	0.0027933000000000003	0.11971287424469633
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.11971287424469633
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.11971287424469633
BRITTLE CORNEA SYNDROME	0.0027933000000000003	0.11971287424469633
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0027933000000000003	0.11971287424469633
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.11971287424469633
RETINAL VENOUS BEADING	0.0027933000000000003	0.11971287424469633
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0027933000000000003	0.11971287424469633
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.11971287424469633
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.11971287424469633
BARBER-SAY SYNDROME; BBRSAY	0.0027933000000000003	0.11971287424469633
MARSHALL-SMITH SYNDROME; MRSHSS	0.0027933000000000003	0.11971287424469633
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0027933000000000003	0.11971287424469633
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.11971287424469633
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0027933000000000003	0.11971287424469633
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.11971287424469633
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0027933000000000003	0.11971287424469633
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.11971287424469633
CONE-ROD DYSTROPHY 1; CORD1	0.0027933000000000003	0.11971287424469633
RAMON SYNDROME	0.0027933000000000003	0.11971287424469633
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.0027933000000000003	0.11971287424469633
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.11971287424469633
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.11971287424469633
PRIMROSE SYNDROME; PRIMS	0.0027933000000000003	0.11971287424469633
PAGET DISEASE OF BONE 3; PDB3	0.0027933000000000003	0.11971287424469633
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.11971287424469633
MORQUIO SYNDROME A	0.0027933000000000003	0.11971287424469633
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.11971287424469633
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.11971287424469633
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.11971287424469633
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0027933000000000003	0.11971287424469633
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.11971287424469633
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.11971287424469633
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0027933000000000003	0.11971287424469633
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.0027933000000000003	0.11971287424469633
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.11971287424469633
ABCD SYNDROME	0.0027933000000000003	0.11971287424469633
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0027933000000000003	0.11971287424469633
N SYNDROME	0.0027933000000000003	0.11971287424469633
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0027933000000000003	0.11971287424469633
BRANCHIOOTIC SYNDROME 2	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.11971287424469633
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.11971287424469633
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.11971287424469633
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.11971287424469633
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.11971287424469633
ANUS, IMPERFORATE	0.0027933000000000003	0.11971287424469633
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0027933000000000003	0.11971287424469633
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.0027933000000000003	0.11971287424469633
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.0027933000000000003	0.11971287424469633
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.11971287424469633
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.11971287424469633
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0027933000000000003	0.11971287424469633
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.11971287424469633
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.0027933000000000003	0.11971287424469633
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.11971287424469633
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.11971287424469633
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0027933000000000003	0.11971287424469633
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0027933000000000003	0.11971287424469633
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.11971287424469633
NEUROFIBROMATOSIS, TYPE II	0.0027933000000000003	0.11971287424469633
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0027933000000000003	0.11971287424469633
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.0027933000000000003	0.11971287424469633
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027933000000000003	0.11971287424469633
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0027933000000000003	0.11971287424469633
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0027933000000000003	0.11971287424469633
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.0027933000000000003	0.11971287424469633
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.0027933000000000003	0.11971287424469633
CHIARI MALFORMATION TYPE I	0.0027933000000000003	0.11971287424469633
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0027933000000000003	0.11971287424469633
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.11971287424469633
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.11971287424469633
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0027933000000000003	0.11971287424469633
KEUTEL SYNDROME; KTLS	0.0027933000000000003	0.11971287424469633
CLEIDOCRANIAL DYSPLASIA; CCD	0.0027933000000000003	0.11971287424469633
TUNE DEAFNESS	0.0027933000000000003	0.11971287424469633
SPINOCEREBELLAR ATAXIA 13	0.0027933000000000003	0.11971287424469633
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0027933000000000003	0.11971287424469633
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.11971287424469633
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0027933000000000003	0.11971287424469633
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.11971287424469633
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.11971287424469633
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.11971287424469633
BRITTLE CORNEA SYNDROME 2; BCS2	0.0027933000000000003	0.11971287424469633
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0027933000000000003	0.11971287424469633
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0027933000000000003	0.11971287424469633
IVIC SYNDROME	0.0027933000000000003	0.11971287424469633
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.0027933000000000003	0.11971287424469633
NATHALIE SYNDROME	0.0027933000000000003	0.11971287424469633
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.11971287424469633
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00254453	0.10905130129304304
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00254453	0.10905130129304304
#609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	0.00254453	0.10905130129304304
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00254453	0.10905130129304304
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.00254453	0.10905130129304304
#607084 DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31;;WHIRLER, MOUSE, HOMOLOG OF	0.00254453	0.10905130129304304
SPONDYLOPERIPHERAL DYSPLASIA	0.00254453	0.10905130129304304
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00254453	0.10905130129304304
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00254453	0.10905130129304304
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00254453	0.10905130129304304
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00254453	0.10905130129304304
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00254453	0.10905130129304304
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00254453	0.10905130129304304
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00254453	0.10905130129304304
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00254453	0.10905130129304304
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00254453	0.10905130129304304
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00254453	0.10905130129304304
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00254453	0.10905130129304304
DEAFNESS, Y-LINKED 1	0.00254453	0.10905130129304304
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00254453	0.10905130129304304
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00254453	0.10905130129304304
WOLFRAM SYNDROME 2; WFS2	0.00254453	0.10905130129304304
WAARDENBURG SYNDROME, TYPE IIB	0.00254453	0.10905130129304304
FOUNTAIN SYNDROME	0.00254453	0.10905130129304304
#609006 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED	0.00254453	0.10905130129304304
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00254453	0.10905130129304304
IMMUNODEFICIENCY 47	0.00254453	0.10905130129304304
#154780 MARSHALL SYNDROME; MRSHS	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00254453	0.10905130129304304
STICKLER SYNDROME, TYPE V; STL5	0.00254453	0.10905130129304304
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00254453	0.10905130129304304
DEAFNESS, Y-LINKED 2; DFNY2	0.00254453	0.10905130129304304
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00254453	0.10905130129304304
OTODENTAL DYSPLASIA	0.00254453	0.10905130129304304
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00254453	0.10905130129304304
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00254453	0.10905130129304304
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00254453	0.10905130129304304
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00254453	0.10905130129304304
Deafness, autosomal recessive 113	0.00254453	0.10905130129304304
#608565 DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00254453	0.10905130129304304
ENLARGED VESTIBULAR AQUEDUCT	0.00254453	0.10905130129304304
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00254453	0.10905130129304304
#610220 DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	0.00254453	0.10905130129304304
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00254453	0.10905130129304304
#220290 DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1ADEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED	0.00254453	0.10905130129304304
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00254453	0.10905130129304304
#606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	0.00254453	0.10905130129304304
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00254453	0.10905130129304304
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00254453	0.10905130129304304
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00254453	0.10905130129304304
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00254453	0.10905130129304304
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00254453	0.10905130129304304
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00254453	0.10905130129304304
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.10905130129304304
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00254453	0.10905130129304304
RETINITIS PIGMENTOSA 59; RP59	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00254453	0.10905130129304304
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00254453	0.10905130129304304
DYSTONIA, JUVENILE-ONSET	0.00254453	0.10905130129304304
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00254453	0.10905130129304304
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00254453	0.10905130129304304
STICKLER SYNDROME, TYPE II	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00254453	0.10905130129304304
#234580 HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00254453	0.10905130129304304
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00254453	0.10905130129304304
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00254453	0.10905130129304304
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00254453	0.10905130129304304
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00254453	0.10905130129304304
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00254453	0.10905130129304304
HYPERLEUCINE-ISOLEUCINEMIA	0.00254453	0.10905130129304304
#616357 DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40	0.00254453	0.10905130129304304
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00254453	0.10905130129304304
#613865 DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00254453	0.10905130129304304
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00254453	0.10905130129304304
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00254453	0.10905130129304304
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00254453	0.10905130129304304
NEURAMINIDASE DEFICIENCY	0.00254453	0.10905130129304304
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00254453	0.10905130129304304
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00254453	0.10905130129304304
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00254453	0.10905130129304304
#614861 DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	0.00254453	0.10905130129304304
#616340 DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67	0.00254453	0.10905130129304304
FRONTOMETAPHYSEAL DYSPLASIA	0.00254453	0.10905130129304304
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00254453	0.10905130129304304
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00254453	0.10905130129304304
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00254453	0.10905130129304304
SPINOCEREBELLAR ATAXIA 31	0.00254453	0.10905130129304304
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00254453	0.10905130129304304
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00254453	0.10905130129304304
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00254453	0.10905130129304304
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00254453	0.10905130129304304
NASODIGITOACOUSTIC SYNDROME	0.00254453	0.10905130129304304
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00254453	0.10905130129304304
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00254453	0.10905130129304304
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.10905130129304304
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00254453	0.10905130129304304
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00254453	0.10905130129304304
#607039 DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	0.00254453	0.10905130129304304
#608389 BRANCHIOOTIC SYNDROME 3; BOS3;;BO SYNDROME 3	0.00254453	0.10905130129304304
#607841 DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	0.00254453	0.10905130129304304
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00254453	0.10905130129304304
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00254453	0.10905130129304304
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00254453	0.10905130129304304
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.00254453	0.10905130129304304
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00254453	0.10905130129304304
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00254453	0.10905130129304304
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00254453	0.10905130129304304
CHANARIN-DORFMAN SYNDROME	0.00254453	0.10905130129304304
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00254453	0.10905130129304304
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00254453	0.10905130129304304
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00254453	0.10905130129304304
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00254453	0.10905130129304304
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00254453	0.10905130129304304
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.00254453	0.10905130129304304
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00254453	0.10905130129304304
PERRAULT SYNDROME 2; PRLTS2	0.00254453	0.10905130129304304
#613707 LEOPARD SYNDROME 3; LPRD3	0.00254453	0.10905130129304304
PAPILLORENAL SYNDROME	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00254453	0.10905130129304304
MENTAL RETARDATION, X-LINKED 46	0.00254453	0.10905130129304304
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00254453	0.10905130129304304
ERMINE PHENOTYPE	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00254453	0.10905130129304304
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00254453	0.10905130129304304
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00254453	0.10905130129304304
#603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	0.00254453	0.10905130129304304
USHER SYNDROME, TYPE IG	0.00254453	0.10905130129304304
#607453 DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	0.00254453	0.10905130129304304
USHER SYNDROME, TYPE IIIA	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00254453	0.10905130129304304
Deafness, autosomal recessive 99	0.00254453	0.10905130129304304
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00254453	0.10905130129304304
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00254453	0.10905130129304304
ALPORT SYNDROME, X-LINKED; ATS	0.00254453	0.10905130129304304
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.00254453	0.10905130129304304
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00254453	0.10905130129304304
DEAFNESS, X-LINKED 1	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00254453	0.10905130129304304
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00254453	0.10905130129304304
WOODHOUSE-SAKATI SYNDROME	0.00254453	0.10905130129304304
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00254453	0.10905130129304304
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00254453	0.10905130129304304
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00254453	0.10905130129304304
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.00254453	0.10905130129304304
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00254453	0.10905130129304304
STICKLER SYNDROME, TYPE III	0.00254453	0.10905130129304304
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00254453	0.10905130129304304
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00254453	0.10905130129304304
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00254453	0.10905130129304304
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00254453	0.10905130129304304
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00254453	0.10905130129304304
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00254453	0.10905130129304304
REFSUM DISEASE	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00254453	0.10905130129304304
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00254453	0.10905130129304304
THYROCEREBRORETINAL SYNDROME	0.00254453	0.10905130129304304
SPONDYLOOCULAR SYNDROME; SOS	0.00254453	0.10905130129304304
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.00254453	0.10905130129304304
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.00254453	0.10905130129304304
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00254453	0.10905130129304304
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00254453	0.10905130129304304
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00254453	0.10905130129304304
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00254453	0.10905130129304304
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00254453	0.10905130129304304
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00254453	0.10905130129304304
OPTIC ATROPHY 8	0.00254453	0.10905130129304304
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00254453	0.10905130129304304
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.00254453	0.10905130129304304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00254453	0.10905130129304304
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00254453	0.10905130129304304
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00254453	0.10905130129304304
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00254453	0.10905130129304304
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00254453	0.10905130129304304
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.00254453	0.10905130129304304
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0021193920000000003	0.09083109869015696
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.09083109869015696
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0021193920000000003	0.09083109869015696
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.0021193920000000003	0.09083109869015696
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0021193920000000003	0.09083109869015696
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0021193920000000003	0.09083109869015696
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0021193920000000003	0.09083109869015696
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0021193920000000003	0.09083109869015696
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0021193920000000003	0.09083109869015696
LISSENCEPHALY 2; LIS2	0.0021193920000000003	0.09083109869015696
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.09083109869015696
ALAZAMI-YUAN SYNDROME	0.0021193920000000003	0.09083109869015696
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0021193920000000003	0.09083109869015696
JABERI-ELAHI SYNDROME; JABELS	0.0021193920000000003	0.09083109869015696
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0021193920000000003	0.09083109869015696
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0021193920000000003	0.09083109869015696
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0021193920000000003	0.09083109869015696
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0021193920000000003	0.09083109869015696
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0021193920000000003	0.09083109869015696
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.0021193920000000003	0.09083109869015696
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0021193920000000003	0.09083109869015696
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021193920000000003	0.09083109869015696
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0021193920000000003	0.09083109869015696
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.0021193920000000003	0.09083109869015696
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0021193920000000003	0.09083109869015696
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.09083109869015696
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0021193920000000003	0.09083109869015696
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.0021193920000000003	0.09083109869015696
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.0021193920000000003	0.09083109869015696
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0021193920000000003	0.09083109869015696
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0021193920000000003	0.09083109869015696
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0021193920000000003	0.09083109869015696
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0021193920000000003	0.09083109869015696
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021193920000000003	0.09083109869015696
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0021193920000000003	0.09083109869015696
CEREBELLOFACIODENTAL SYNDROME	0.0021193920000000003	0.09083109869015696
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0021193920000000003	0.09083109869015696
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0021193920000000003	0.09083109869015696
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0021193920000000003	0.09083109869015696
MEVALONIC ACIDURIA; MEVA	0.0021193920000000003	0.09083109869015696
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0021193920000000003	0.09083109869015696
HEART AND BRAIN MALFORMATION SYNDROME	0.0021193920000000003	0.09083109869015696
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0021193920000000003	0.09083109869015696
LISSENCEPHALY 4	0.0021193920000000003	0.09083109869015696
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0021193920000000003	0.09083109869015696
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0021193920000000003	0.09083109869015696
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0021193920000000003	0.09083109869015696
RING CHROMOSOME 14 SYNDROME	0.0021193920000000003	0.09083109869015696
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0021193920000000003	0.09083109869015696
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0021193920000000003	0.09083109869015696
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0021193920000000003	0.09083109869015696
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.0021193920000000003	0.09083109869015696
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.09083109869015696
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.09083109869015696
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0021193920000000003	0.09083109869015696
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.09083109869015696
MARINESCO-SJOGREN SYNDROME; MSS	0.0021193920000000003	0.09083109869015696
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0021193920000000003	0.09083109869015696
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0021193920000000003	0.09083109869015696
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0021193920000000003	0.09083109869015696
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0021193920000000003	0.09083109869015696
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.09083109869015696
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0021193920000000003	0.09083109869015696
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0021193920000000003	0.09083109869015696
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.09083109869015696
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.09083109869015696
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0021193920000000003	0.09083109869015696
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0021193920000000003	0.09083109869015696
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.09083109869015696
AICARDI-GOUTIERES SYNDROME 6	0.0021193920000000003	0.09083109869015696
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.09083109869015696
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0021193920000000003	0.09083109869015696
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.0021193920000000003	0.09083109869015696
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0021193920000000003	0.09083109869015696
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.09083109869015696
FUMARASE DEFICIENCY; FMRD	0.0021193920000000003	0.09083109869015696
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.09083109869015696
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.0021193920000000003	0.09083109869015696
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0021193920000000003	0.09083109869015696
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.09083109869015696
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021193920000000003	0.09083109869015696
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0021193920000000003	0.09083109869015696
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.0021193920000000003	0.09083109869015696
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0021193920000000003	0.09083109869015696
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.09083109869015696
BETA-UREIDOPROPIONASE DEFICIENCY	0.0021193920000000003	0.09083109869015696
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.09083109869015696
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0021193920000000003	0.09083109869015696
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0021193920000000003	0.09083109869015696
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.0021193920000000003	0.09083109869015696
HOLOPROSENCEPHALY 1; HPE1	0.0021193920000000003	0.09083109869015696
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0021193920000000003	0.09083109869015696
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0021193920000000003	0.09083109869015696
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0021193920000000003	0.09083109869015696
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021193920000000003	0.09083109869015696
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0021193920000000003	0.09083109869015696
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0021193920000000003	0.09083109869015696
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.09083109869015696
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0021193920000000003	0.09083109869015696
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0021193920000000003	0.09083109869015696
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.0021193920000000003	0.09083109869015696
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.09083109869015696
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.09083109869015696
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0021193920000000003	0.09083109869015696
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0021193920000000003	0.09083109869015696
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0021193920000000003	0.09083109869015696
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.0021193920000000003	0.09083109869015696
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0021193920000000003	0.09083109869015696
ADAMS-OLIVER SYNDROME 2; AOS2	0.0021193920000000003	0.09083109869015696
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0021193920000000003	0.09083109869015696
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.09083109869015696
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.09083109869015696
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0021193920000000003	0.09083109869015696
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0021193920000000003	0.09083109869015696
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.09083109869015696
AICARDI-GOUTIERES SYNDROME 5	0.0021193920000000003	0.09083109869015696
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0021193920000000003	0.09083109869015696
HOLOPROSENCEPHALY 2; HPE2	0.0021193920000000003	0.09083109869015696
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.09083109869015696
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0021193920000000003	0.09083109869015696
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0021193920000000003	0.09083109869015696
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.0021193920000000003	0.09083109869015696
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.09083109869015696
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.0546647220949603
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00127551	0.0546647220949603
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.0546647220949603
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.0546647220949603
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00127551	0.0546647220949603
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00127551	0.0546647220949603
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00127551	0.0546647220949603
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.0546647220949603
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00127551	0.0546647220949603
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00127551	0.0546647220949603
Cri du Chat Syndrome (5p deletion)	0.00127551	0.0546647220949603
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.0546647220949603
ALLAN-HERNDON-DUDLEY SYNDROME	0.00127551	0.0546647220949603
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00127551	0.0546647220949603
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.0546647220949603
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00127551	0.0546647220949603
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.0546647220949603
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.0546647220949603
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00127551	0.0546647220949603
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.0546647220949603
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00127551	0.0546647220949603
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.0546647220949603
FACIOCARDIOMELIC SYNDROME	0.00127551	0.0546647220949603
BARDET-BIEDL SYNDROME 20	0.00127551	0.0546647220949603
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.0546647220949603
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.0546647220949603
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.0546647220949603
MENKES DISEASE	0.00127551	0.0546647220949603
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00127551	0.0546647220949603
RHIZOMELIC SYNDROME	0.00127551	0.0546647220949603
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.0546647220949603
LAMBOTTE SYNDROME	0.00127551	0.0546647220949603
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.0546647220949603
COHEN SYNDROME	0.00127551	0.0546647220949603
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00127551	0.0546647220949603
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.0546647220949603
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.0546647220949603
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.0546647220949603
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00127551	0.0546647220949603
SECKEL SYNDROME 4	0.00127551	0.0546647220949603
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.0546647220949603
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00127551	0.0546647220949603
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.0546647220949603
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.0546647220949603
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00127551	0.0546647220949603
2p15-16.1 microdeletion syndrome	0.00127551	0.0546647220949603
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.0546647220949603
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00127551	0.0546647220949603
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00127551	0.0546647220949603
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00127551	0.0546647220949603
RUVALCABA SYNDROME	0.00127551	0.0546647220949603
15q24 recurrent microdeletion syndrome	0.00127551	0.0546647220949603
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00127551	0.0546647220949603
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.0546647220949603
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.0546647220949603
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.0546647220949603
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.0546647220949603
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00127551	0.0546647220949603
Angelman syndrome (Type 1)	0.00127551	0.0546647220949603
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00127551	0.0546647220949603
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.0546647220949603
Angelman syndrome (Type 2)	0.00127551	0.0546647220949603
9q subtelomeric deletion syndrome	0.00127551	0.0546647220949603
SUPRABULBAR PARESIS, CONGENITAL	0.00127551	0.0546647220949603
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.0546647220949603
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.0546647220949603
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.0546647220949603
Wolf-Hirschhorn Syndrome	0.00127551	0.0546647220949603
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00127551	0.0546647220949603
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00127551	0.0546647220949603
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.0546647220949603
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.0546647220949603
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.0546647220949603
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.0546647220949603
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00127551	0.0546647220949603
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.0546647220949603
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.0546647220949603
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.0546647220949603
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.0546647220949603
Miller-Dieker syndrome (MDS)	0.00127551	0.0546647220949603
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.0546647220949603
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00127551	0.0546647220949603
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00127551	0.0546647220949603
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00127551	0.0546647220949603
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00127551	0.0546647220949603
MARTSOLF SYNDROME	0.00127551	0.0546647220949603
PAINE SYNDROME	0.00127551	0.0546647220949603
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.0546647220949603
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00127551	0.0546647220949603
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.0546647220949603
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00127551	0.0546647220949603
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00127551	0.0546647220949603
INCONTINENTIA PIGMENTI; IP	0.00127551	0.0546647220949603
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.0546647220949603
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00127551	0.0546647220949603
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00127551	0.0546647220949603
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.0546647220949603
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.0546647220949603
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.0546647220949603
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00127551	0.0546647220949603
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.0546647220949603
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00127551	0.0546647220949603
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.0546647220949603
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.0546647220949603
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00127551	0.0546647220949603
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00127551	0.0546647220949603
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.0546647220949603
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.0546647220949603
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.0546647220949603
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.0546647220949603
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00127551	0.0546647220949603
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00127551	0.0546647220949603
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.0546647220949603
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00127551	0.0546647220949603
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.0546647220949603
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.0546647220949603
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00127551	0.0546647220949603
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00127551	0.0546647220949603
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00127551	0.0546647220949603
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00127551	0.0546647220949603
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00127551	0.0546647220949603
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.0546647220949603
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.0546647220949603
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00127551	0.0546647220949603
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.0546647220949603
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.0546647220949603
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00127551	0.0546647220949603
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00127551	0.0546647220949603
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00127551	0.0546647220949603
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00127551	0.0546647220949603
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00127551	0.0546647220949603
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.0546647220949603
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00127551	0.0546647220949603
CARDIAC LIPIDOSIS, FAMILIAL	0.00127551	0.0546647220949603
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00127551	0.0546647220949603
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.0546647220949603
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.0546647220949603
MARDEN-WALKER SYNDROME	0.00127551	0.0546647220949603
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.0546647220949603
SAY SYNDROME	0.00127551	0.0546647220949603
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.0546647220949603
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00127551	0.0546647220949603
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.0546647220949603
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.0546647220949603
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.0546647220949603
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.0546647220949603
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.0546647220949603
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.0546647220949603
HYPERREFLEXIA	0.00127551	0.0546647220949603
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00127551	0.0546647220949603
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.0546647220949603
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00127551	0.0546647220949603
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.0546647220949603
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.0546647220949603
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00127551	0.0546647220949603
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.0546647220949603
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.0546647220949603
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00127551	0.0546647220949603
MECKEL SYNDROME 12; MKS12	0.00127551	0.0546647220949603
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.0546647220949603
PHENYLKETONURIA	0.00127551	0.0546647220949603
WARBURG MICRO SYNDROME 1	0.00127551	0.0546647220949603
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.0546647220949603
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00127551	0.0546647220949603
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.0546647220949603
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00127551	0.0546647220949603
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.0546647220949603
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.0546647220949603
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.0546647220949603
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00127551	0.0546647220949603
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.0546647220949603
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.036166376595196656
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.036166376595196656
JOUBERT SYNDROME 25	0.000843882	0.036166376595196656
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.036166376595196656
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.036166376595196656
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.036166376595196656
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.036166376595196656
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.036166376595196656
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.036166376595196656
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.036166376595196656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.036166376595196656
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.036166376595196656
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.036166376595196656
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.036166376595196656
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.036166376595196656
PELLAGRA-LIKE SYNDROME	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.036166376595196656
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.036166376595196656
NOONAN SYNDROME 9; NS9	0.000843882	0.036166376595196656
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.036166376595196656
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000843882	0.036166376595196656
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.036166376595196656
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000843882	0.036166376595196656
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.036166376595196656
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.036166376595196656
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000843882	0.036166376595196656
SULFOCYSTEINURIA	0.000843882	0.036166376595196656
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000843882	0.036166376595196656
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.036166376595196656
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.036166376595196656
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.036166376595196656
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.036166376595196656
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.036166376595196656
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.036166376595196656
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.036166376595196656
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.036166376595196656
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000843882	0.036166376595196656
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.036166376595196656
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.036166376595196656
NETHERTON SYNDROME; NETH	0.000843882	0.036166376595196656
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.036166376595196656
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.036166376595196656
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.036166376595196656
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.036166376595196656
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.036166376595196656
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.036166376595196656
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.036166376595196656
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.036166376595196656
KETOADIPICACIDURIA	0.000843882	0.036166376595196656
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.036166376595196656
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000843882	0.036166376595196656
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.036166376595196656
EVEN-PLUS SYNDROME	0.000843882	0.036166376595196656
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.036166376595196656
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.036166376595196656
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000843882	0.036166376595196656
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.036166376595196656
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.036166376595196656
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.036166376595196656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.036166376595196656
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.036166376595196656
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.036166376595196656
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.036166376595196656
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000843882	0.036166376595196656
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000843882	0.036166376595196656
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.036166376595196656
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.036166376595196656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.036166376595196656
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000843882	0.036166376595196656
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.036166376595196656
XIA-GIBBS SYNDROME	0.000843882	0.036166376595196656
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.036166376595196656
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.036166376595196656
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.036166376595196656
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000843882	0.036166376595196656
JOUBERT SYNDROME 10	0.000843882	0.036166376595196656
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.036166376595196656
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.036166376595196656
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000843882	0.036166376595196656
JOUBERT SYNDROME 26	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.036166376595196656
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.036166376595196656
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.036166376595196656
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.036166376595196656
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.036166376595196656
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.036166376595196656
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.036166376595196656
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.036166376595196656
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.036166376595196656
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.036166376595196656
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.036166376595196656
SCHINDLER DISEASE, TYPE I	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.036166376595196656
REVESZ SYNDROME	0.000843882	0.036166376595196656
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.036166376595196656
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.000843882	0.036166376595196656
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.036166376595196656
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.036166376595196656
PELGER-HUET ANOMALY; PHA	0.000843882	0.036166376595196656
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000843882	0.036166376595196656
SENIOR-LOKEN SYNDROME 9	0.000843882	0.036166376595196656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.036166376595196656
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000843882	0.036166376595196656
Helsmoortel-van der Aa syndrome	0.000843882	0.036166376595196656
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.036166376595196656
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000843882	0.036166376595196656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.036166376595196656
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.036166376595196656
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.036166376595196656
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000843882	0.036166376595196656
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000843882	0.036166376595196656
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.036166376595196656
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.036166376595196656
JOUBERT SYNDROME 6	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.036166376595196656
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.036166376595196656
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.036166376595196656
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000843882	0.036166376595196656
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000843882	0.036166376595196656
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.036166376595196656
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.000843882	0.036166376595196656
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.036166376595196656
ARIMA SYNDROME	0.000843882	0.036166376595196656
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.036166376595196656
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.036166376595196656
MECKEL SYNDROME 13; MKS13	0.000843882	0.036166376595196656
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.036166376595196656
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.036166376595196656
SEPTOOPTIC DYSPLASIA	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.036166376595196656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.036166376595196656
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.036166376595196656
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.036166376595196656
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.036166376595196656
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000843882	0.036166376595196656
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.036166376595196656
JOUBERT SYNDROME 28	0.000843882	0.036166376595196656
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.036166376595196656
NOONAN SYNDROME 5; NS5	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.036166376595196656
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.036166376595196656
JOUBERT SYNDROME 15	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.036166376595196656
JOUBERT SYNDROME 8	0.000843882	0.036166376595196656
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000843882	0.036166376595196656
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000843882	0.036166376595196656
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000843882	0.036166376595196656
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.036166376595196656
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.036166376595196656
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.036166376595196656
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.036166376595196656
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.036166376595196656
Bardet-Biedl syndrome 2	0.000843882	0.036166376595196656
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.036166376595196656
CITRULLINEMIA, CLASSIC	0.000843882	0.036166376595196656
PROPIONIC ACIDEMIA	0.000843882	0.036166376595196656
PYRUVATE CARBOXYLASE DEFICIENCY	0.000843882	0.036166376595196656
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.036166376595196656
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.036166376595196656
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.036166376595196656
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.036166376595196656
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.036166376595196656
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.036166376595196656
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.036166376595196656
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.036166376595196656
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.036166376595196656
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000843882	0.036166376595196656
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.036166376595196656
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.036166376595196656
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.036166376595196656
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.036166376595196656
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.036166376595196656
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.036166376595196656
OROTIC ACIDURIA	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.036166376595196656
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.036166376595196656
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.036166376595196656
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.036166376595196656
CULLER-JONES SYNDROME; CJS	0.000843882	0.036166376595196656
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.036166376595196656
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.036166376595196656
ELEJALDE DISEASE	0.000843882	0.036166376595196656
ARGININOSUCCINIC ACIDURIA	0.000843882	0.036166376595196656
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.036166376595196656
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000843882	0.036166376595196656
AUSTRALIA ANTIGEN	0.000843882	0.036166376595196656
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.036166376595196656
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.036166376595196656
NAVAJO NEUROHEPATOPATHY	0.000843882	0.036166376595196656
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000843882	0.036166376595196656
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.036166376595196656
GAUCHER DISEASE, TYPE II	0.000843882	0.036166376595196656
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.036166376595196656
RAHMAN SYNDROME	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.036166376595196656
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.036166376595196656
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.036166376595196656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.036166376595196656
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.036166376595196656
300270 ADRENOMYODYSTROPHY	0.000843882	0.036166376595196656
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000843882	0.036166376595196656
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.036166376595196656
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.036166376595196656
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.036166376595196656
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.036166376595196656
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.036166376595196656
WAISMAN SYNDROME; WSMN	0.000843882	0.036166376595196656
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.036166376595196656
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000843882	0.036166376595196656
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.036166376595196656
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.036166376595196656
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.036166376595196656
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.036166376595196656
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000843882	0.036166376595196656
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.036166376595196656
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.036166376595196656
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.036166376595196656
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000843882	0.036166376595196656
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.036166376595196656
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000843882	0.036166376595196656
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.036166376595196656
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.036166376595196656
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000843882	0.036166376595196656
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.036166376595196656
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.036166376595196656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000843882	0.036166376595196656
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.036166376595196656
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.036166376595196656
JOUBERT SYNDROME 7	0.000843882	0.036166376595196656
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.036166376595196656
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.036166376595196656
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000843882	0.036166376595196656
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.036166376595196656
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.036166376595196656
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.036166376595196656
JOUBERT SYNDROME 27	0.000843882	0.036166376595196656
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.036166376595196656
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.036166376595196656
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.036166376595196656
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.036166376595196656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.036166376595196656
#300555 DENT DISEASE 2	0.000843882	0.036166376595196656
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.036166376595196656
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.036166376595196656
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.036166376595196656
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000843882	0.036166376595196656
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.036166376595196656
611961 STEVENSON-CAREY SYNDROME	0.000843882	0.036166376595196656
HARTNUP DISORDER	0.000843882	0.036166376595196656
NOONAN SYNDROME 2; NS2	0.000843882	0.036166376595196656
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.036166376595196656
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.036166376595196656
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000843882	0.036166376595196656
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.036166376595196656
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.036166376595196656
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.036166376595196656
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000843882	0.036166376595196656
GLYCEROL KINASE DEFICIENCY; GKD	0.000843882	0.036166376595196656
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000843882	0.036166376595196656
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.036166376595196656
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.036166376595196656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.036166376595196656
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.036166376595196656
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.036166376595196656
